Vaccines and Related Biological Products Advisory Committee Curriculum Vitae Steven Pergam
Vaccines and Related Biological Products Advisory Committee Curriculum Vitae Steven Pergam, CBER, Biologics
Non-FDA
VRBPAC-Curriculum-Vitae-Steven-Pergam STEVEN AARON PERGAM, MD, MPH, FIDSA
January 1 2020
1. PERSONAL DATA Place of Birth: Pine Ridge, South Dakota, USA
2. EDUCATION
19891993
Dartmouth College, Hanover, NH BA (cum laude)
19941998
University of Nebraska School of Medicine, Omaha, NE MD, with distinction
20052008
University of Washington School of Public Health, Seattle, WA MPH, Epidemiology
3. POSTGRADUATE TRAINING
19982001
Resident in Internal Medicine, University of New Mexico Albuquerque, NM
20052009
Senior Fellow, Infectious Diseases, University of Washington Seattle, WA
2015-2016
Certificate in Patient Safety and Quality, Department of Medicine, University of Washington
4. FACULTY POSITIONS
20022005
Assistant Professor of Medicine, Hospitalist Program University of New Mexico School of Medicine, Albuquerque, NM
20092011
Associate in Clinical Research Fred Hutchinson Cancer Research Center, Seattle, WA
20092011
Associate in Vaccine and Infectious Diseases Fred Hutchinson Cancer Research Center, Seattle, WA
20092011
Acting Instructor, Department of Medicine Division of Allergy and Infectious Diseases University of Washington, Seattle, WA
20112017
Assistant Member, Clinical Research Division Fred Hutchinson Cancer Research Center, Seattle, WA
20112017
Assistant Member, Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center, Seattle, WA
20112017
Assistant Professor, Department of Medicine Division of Allergy and Infectious Diseases University of Washington, Seattle, WA
20122017
Adjunct Assistant Professor, Department of Epidemiology School of Public Health University of Washington, Seattle, WA
Pergam, SA - CV Page 1
2017present Associate Member, Clinical Research Division Fred Hutchinson Cancer Research Center, Seattle, WA
2017present Associate Member, Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center, Seattle, WA
2017present Adjunct Associate Professor, Department of Epidemiology School of Public Health University of Washington, Seattle, WA
2017present Associate Professor, Department of Medicine Division of Allergy and Infectious Diseases University of Washington, Seattle, WA
5. HOSPITAL POSITIONS HELD
20012002
Chief Medical Resident in Internal Medicine Instructor in Medicine with Letter of Academic Title University of New Mexico School of Medicine, Albuquerque, NM
20012005
Attending Physician, Hospitalist Inpatient and General Medicine Consult, Internal Medicine, University of New Mexico
20052011
Attending Physician, University of Washington, Roosevelt Virology Clinic (0.5 days per week)
2005
Interim Director, Adult Cystic Fibrosis Clinic University of New Mexico School of Medicine, Albuquerque, NM
2009present Attending Physician, Infectious Diseases Consultation, Seattle Cancer Care Alliance (6-8 weeks/year)
20112013
Associate Director, Infection Control Seattle Cancer Care Alliance, Seattle, WA
2013present Attending Physician, Infectious Diseases Consult Clinic (Variable)
2014present Medical Director of Infection Control Seattle Cancer Care Alliance, Seattle, WA
6. CURRENT EMPLOYMENT N/A
7. HONORS
19961997
19961997 19971998 1998 19981999 20012002 20032004
20042005
Nebraska Medical Education Foundation - Merle M. Musselman, MD Academic Scholarship University of Nebraska Student Leadership Scholarship University of Nebraska Regent's Scholarship (full tuition) Alpha Omega Alpha, Clinical Excellence Award University of New Mexico, Intern of the Year University of New Mexico, Resident Teaching Award William Hardy Teaching Award, Internal Medicine Attending of the Year University of New Mexico, Albuquerque, NM Class of 2005 Erwin W. Lewis Clinical Khatali Teaching Award
Pergam, SA - CV Page 2
2005 2007 2008 2008
2008 2008 2009 2009 2010 2012 2014 2017 2018
2019
University of New Mexico, Albuquerque, NM Ortho-McNeil Infectious Diseases Scholar Travel Award Infectious Diseases Society of America Fellows Travel Award ASMBT Fellows Travel Award Best Clinical Abstract, IDSA sponsored - 2nd Infections in Cancer Symposium, Houston, TX ICAAC Annual Meeting ID Fellow Grant Award Joel Meyers Infectious Diseases Scholarship Grant, FHCRC ASBMT New Investigator Award ICAAC Travel Grant, selected George McCracken Fellow IDSA Medical Scholars Program Mentor IDSA Medical Scholars Program Mentor Elected to Fellow, Infectious Disease Society of America (FIDSA) AJIC: American Journal of Infection Control Certificate of Outstanding Reviewing Dr. Ali Al-Johani Award, FHCRC, in recognition of exemplary clinical medical care and compassion to cancer patients and families Selected as GeekWire "Geek of the Week" (January 2019)
8. BOARD CERTIFICATION American Board of Internal Medicine
9. LICENSURE Washington State Medical License
Internal Medicine Infectious Diseases
2005present
20012011 2007present
10. PROFESSIONAL ORGANIZATIONS
1998 1999 2008 2008 2008 2008 2008 2008 2009 2011 2011 2013 2018
Alpha Omega Alpha, Nebraska Alpha Chapter American Federation of Medical Research American Society of Blood and Marrow Transplantation American Society of Transplantation Infectious Disease Society of America Immunocompromised Host Society Institute of Translational Health Sciences, University of Washington The Transplantation Society American Society for Microbiology Society for Healthcare Epidemiology of America American Society of Hematology Association for Professionals in Infection Control and Epidemiology Immunocompromised Host Society (ICHS)
11. TEACHING RESPONSIBILITIES
A. Courses:
20012005 Lecturer, Clinical Skills Course, University of New Mexico
20072010 Moderator, Hu-Bio 534, Viral Disease Small Group Discussion, University of Washington
2009
Lecturer, "Infections in Transplantation", Infectious Diseases Fellows Board Review, University of Washington
2010-present Lecturer, "Respiratory Viruses in Immunocompromised Patients", Infectious Diseases Fellows Board Review, University of Washington
Pergam, SA - CV Page 3
20102012
Lecturer, "Latent Viral Infections in HSCT recipients" and "Respiratory Viruses: The Not so "Common" Cold(s)", Infectious Diseases Fellows Orientation, University of Washington
20112013 2011present 20122017 2012
Lecturer, "Infectious Emergencies in Immunocompromised Hosts." Hematology-Oncology Advanced Care Practitioner Training Course, University of Washington (1 hr)
Lecturer, "How to Successfully Apply to Medical School." Summer Undergraduate Research Program, Fred Hutchinson Cancer Research Center (1 hr)
Lecturer, Hu-Bio 600B, "What Antibiotic Do I Choose?" University of Washington Medical Student Capstone (2 hrs)
Lecturer, Micro 442, "An Introduction to Infectious Disease Epidemiology and Infection Control." University of Washington
2013present Lecturer, "Viral Infections in HSCT recipients", Infectious Diseases Fellows Orientation, University of Washington (1 hr)
2013
Lecturer, NURS454 Clinical Nursing Care of Adults II, "It's Cancer! Why Do We Care About Infections?" Seattle University, Jan 2013
2014present Lecturer, "Infections and Infection Control in Transplantation", BMT Nurses Training Course, SCCA (2@ 1 hr)
2017
Lecturer, EPI 583, "Clinical Epidemiology of Hospital & Environmental Infections in HighRisk Cancer Patients", University of Washington, Apr 11, 2017 (1 hr)
2017
Lecturer: "Opportunistic Viral Infections in HSCT Patients", ID Fellows Orientation, UW, July 5, 2017
2018
Lecturer: "Pulmonary Infections in Immunocompromised Hosts," Pulmonary Fellows, UW, June 7, 2018
2018
Lecturer: "Infectious Disease in Oncology" Hematology/Oncology Fellows Lecture Series, October 19, 2018
CME/CNE Courses:
2010 2011 2014, 2019 2014
2014 2015 2015present
2016 2017 2017
"Infections in Transplantation." OptumHealth 2011 Transplant Conference (CME). Scottsdale, AZ. Mar 2010.
Primary Care Management of HIV Patients: Current Concepts in Drug Therapy (University of Washington CME). Seattle, WA. Apr 2011.
"Shingles" Northwest Geriatric Education Center (NWGEC), (University of Washington CNE), Seattle, WA May 2014, April 2019
"Preventing Respiratory Viruses in Cancer and Transplant Patients - Preparing for the
2014-2015 Season" Clinical Oncology Grand Rounds, UW/FHCRC CME, Seattle, WA, Sept 30, 2014.
"Ebola and the SCCA: Preparing the Center for High-Risk Pathogens" Clinical Oncology Grand Rounds, UW/FHCRC CME, Seattle, WA, Oct 21, 2014.
Lecturer. "Infectious Diseases in Transplantation", Nursing Management of the BMT Patient Course, SCCA, CNE, Oct 21, 2015
Lecturer: "Infectious Diseases in Cancer and Transplant Patients", Hematology/Oncology Fellows Teaching Conference, UW/FHCRC CME, Aug 28, 2015; Aug 12, 2016; September 1, 2017, Oct 19, 2018
"Preventing Respiratory Viruses in Cancer and Transplant Patients", Clinical Oncology
Grand Rounds, UW/FHCRC CME, Seattle, WA, Sept 27, 2016.
"Prevention, Prophylaxis, Treatment: Preparing for Fungus in Hematologic Diseases",
Hematology Grand Rounds, UW/FHCRC CME, Seattle, WA Mar 17, 2017.
Lecturer: "ID Updates and New CMV Studies in HSCT Patients" BMT Nurse's Ed Days, April 12 & 19th 2017
Pergam, SA - CV Page 4
2017present 2017 2017 2018 2018 2019 2019 2019
2020 2020 Other:
Lecturer, "Infectious Complications" BMT Nurses Training Course, SCCA, June 22, 2017, October 3, 2018, January 10, 2019, June 25, 2019
Lecturer: "Infection Prevention During Construction", Infection Prevention Champions Training Day, SCCA, Aug 23, 2017.
Lecturer: "Viral Infections in Transplant Recipients" ASBMT Fall Clinical Education Conference, October 28, 2017
Lecturer/Panelist: "Legionella and Other Waterborne Pathogens in Immunocompromised Patients." APIC pre-conference satellite symposium. Minneapolis, MN, June 12, 2018.
Lecturer: "Infections in Cancer and HCT Recipients." Critical Care Oncology for Nurses. Seattle, WA, Sept 24, 2018.
Lecturer: "Late Infectious Complications after Transplant" LTFU Nursing Summit at SCCA, May 16, 2019
Lecturer: "Cannabis, Cancer and Immunosuppressed Hosts" SCCA Network CME Speakers Series Skagit Valley Hospital in Mount Vernon, WA September 18, 2019
Lecturer: "Legionella and Other Waterborne Pathogens Among High-Risk
Immunocompromised Patient Populations," Washington State Department of Health,/Pall Medical Educational Symposium, Seattle, WA October 30, 2019
Lecturer: "Cannabis, Cancer and Immunosuppressed Hosts" SCCA CME Speakers Series Kadlec Clinic, Kennewick, WA February 4, 2020
Lecturer: "Cannabis, Cancer and Immunosuppressed Hosts" SCCA Network CME Speakers Series MultiCare Center, Tacoma, WA March 20, 2020
20012005 Faculty Supervisor, General Medicine Clinic, University of New Mexico
2008present Member, Infectious Diseases Fellowship Curriculum Committee, University of Washington (UW)
2009
Member, Bioethics Colloquium Planning Committee, Fred Hutchinson Cancer Research Center (FHCRC)
2009present Advisor, Residency and Medical School Applicant and Interview Preparation, FHCRC
2011, 2013
Discussion Leader, Ethics Case Study, Research and Ethics Education Program, FHCRC.
2011present Lecturer, "Infection Control Updates." Quarterly Nurses Education Days, Seattle Cancer Care Alliance (SCCA)
2013, 2014
Moderator, "Pathway to Medicine", Healthcare Professionals Panel, Seattle Pacific University MAPS (Minority Association of Pre-Health Students) May 2013, May 2014.
2013
Lecturer: "Respiratory Viruses", Platinum PA Service Educational Conference, SCCA, Oct 2013
2013
Second Instructor, Manuscript Writing Workshop for Virology and VIDD, University of Washington and FHCRC, Dec 2013.
2014
Lecturer: "Legionella", SCCA Engineering Team, April 2014.
2014present Lecturer: "Infection Control and the SCCA: Getting to Know the Major Pathogens" and "Intro to Quality Projects and Leadership", Infection Prevention Champions Training Day, SCCA
2014
Discussion Leader, Hutch United Mentoring Network (HUMN) mentoring session, FHCRC, Nov 2014
2015
Lecturer, "Understanding the `Guts' of Infection Prevention in Cancer and Transplant Patients", VIDD Seminar, FHCRC, Mar 2015
2015
Lecturer: "Infection Prevention", Cancer Consortium Clinical Research Coordinators
Pergam, SA - CV Page 5
2016 2016 2016
2016 2016 2017 2017 2017
2017 2017 2018 2018 2018 2018 2018-present 2019 2019 2019
2019 2019 2019
Training, SCCA, Apr 2015
Discussion Leader, Hutch United Mentoring Network (HUMN) mentoring session, FHCRC, May 2016
Lecturer, "Updates in Infection Prevention in Cancer and Transplant Patients", VIDD Seminar, FHCRC, May 2016
Lecturer: "Understanding Influenza Vaccination Rates in Caregivers and Household Contacts on Cancer Patients", Northwest Patient Safety Conference, Lynnwood, WA May 2016
Lecturer: "SCCA Influenza Vaccination Campaign for Caregivers and Household Contacts", ID Fellows Conference, UW, Oct 5, 2016
Lecturer: "National APIC Abstract Submission: Tips and Tricks", Puget Sound APIC Webinar, Nov 2, 2016
Panelist: Post-doc Leadership Workshop, UW/FHCRC May 23, 2017
Lecturer: "Emerging Issues in Marijuana Use" General Oncology APP monthly meeting, SCCA June 8, 2017
Moderator: Water and Healthcare-Associated Infections: The Importance of Developing and Implementing a Water Management Plan, APIC Annual Conference, Portland, OR June 14, 2017
Lecturer: "Opportunistic Infections in HSCT Patients" ID Fellows Orientation, UW, July 5, 2017
Panelist: Cancer survivorship patient panel, Symposium on Cancer Survivorship for Clinicians, October 27th 2017
Moderator: Healthcare Laundry and Fungal Infections. APIC Minneapolis, MN June 13, 2018
Moderator: MDR pathogens in premise/hospital plumbing, APIC Minneapolis, MN June 15, 2018
HCT Morbidity and Mortality "A 36 year old woman with eye pain 7 days of allogenic transplant" June 24, 2018, October 10, 2018
Lecturer: Bone Marrow Transplant Nurses Educational Conference "A Targeted Screening Program for TB Screening among HCT Recipients" August 21 & 24, 2018
Panelist: What's New With the Flu Know Your Facts SCCA/FHCRC Facebook Live Q&A, October 16, 2018, October 17, 2019
Lecturer: Science for Staff, March 6, 2019 FHCRC, Seattle, WA
Lecturer: Measles, March 8, 2019 Seattle Cancer Care Alliance, Seattle, WA
Lecturer: "Infection Prevention in the BMT and Immunotherapy populations" C4QI (Comprehensive Cancer Center Consortium Quality Improvement Conference) May 9, 2019
Invited Speaker: Hutch Awards Luncheon, "Researcher and Cancer Survivor" July 18, 2019
Lecturer: Marijuana to Measles: Preventing Infections in Cancer Patients at the Fringes VIDD Seminar, Fred Hutch September 17, 2019
Panelist: "Flu Science 101 What you need to know for the upcoming flu season," October 25, 2019
Pergam, SA - CV Page 6
2019 2020
Faculty Discussant: Breast Cancer Seminar Series: Morbidity & Mortality "Complications of long term steroid use in a patient with metastatic breast cancer" November 21, 2019
Moderator Oral Abstract Session M - Infection and Immunity on Sunday, February 23, 2020
B. MENTORING (* = co-mentor)
Past / Current Trainee
Trainee Name (Where Training
Occurred)
Pre / Post Level
Training Period
Prior Academic Degree/s and Year/s
Prior Academic
Degree Institution/s
Title of Research Project
Current Position of Past Trainees /
Source of Support of Current Trainees
Past
*Ravinder (Vicky) Sandhu (FHCRC)
Post 2008 2011
MD 2004
St.
Risk Factors for
Petersburg CMV Infection in
State Medical R-/D+ HCT
Academy, St. Recipients
Petersburg,
Russia
Family Medicine Resident, Suffolk County, NY
Past Denise Della Pre 2009
(FHCRC)
2010
BS Maui, HI 2013
Low-dose Cidofovir MPH-MHA,
for BK Virus
A.T. Still University
Associated
College of
Hemorrhagic Cystitis Graduate Health,
Hawaii
Past Past Past Past Past
Fillipo Milano* Post (FHCRC)
Alex Weiss Pre (FHCRC)
Farah Sahoo Post (FHCRC)
Valeria Ilieva Post (FHCRC)
Sachiko Seo* Post (FHCRC)
2010 2011
2010 2013
2010 2012
2011 2012
2011 2012
MD 2010
School of
Assessing
Medicine
Prevention
University "La Strategies for CMV
Sapienza", Prevention in Cord
Rome, Italy Blood Transplant
Recipients
Assistant Professor, Division of HematologyOncology, FHCRC and UW
BS 2010
Seattle University, Seattle, WA
Epidemiology and Outcomes of C-Diff in Pediatric HCT
Pediatrics Resident, Seattle Children's, Seattle, WA
MBBS 1997
Fatima Jinnah Treatment of BK
Research
Medical
Hemorrhagic Cystitis Coordinator, Fred
College for in Hematopoietic Hutchinson Cancer
Women,
Cell Transplant
Research Center
Lahore,
Recipients
Pakistan
MD 1997
Medical University Sofia, Sofia, Bulgaria
Fungal infections in Assistant
Cord blood and CMV Professor,
in seronegative HCT Infectious
recipients
Diseases,
University of New
Mexico
MD 1996 Tokyo
Infections in
PhD 2003 University, Lymphoma Patients
Tokyo, Japan Undergoing
Autotransplantation
Chief Physician, Department of Hematology and Oncology, National Cancer Research Center East, Japan
Pergam, SA - CV Page 7
Past
Martha Fitelson (FHCRC)
Pre 2011 2012
Past
Giovanna Travi* (FHCRC)
Post 2009 2013
Past
Thomas Campbell (FHCRC)
Pre 2012 2013
Past
Janelle Wierenga (FHCRC)
Post 2012 2013
Current Victor Chow Post 2010 (FHCRC)
Past
Stephanie Price (FHCRC)
Pre 2012
Current Nicole Boyle Pre 2012 (FHCRC)
BS
MD 2005
BA 2007
DVM 2003 MPH 2013
MD 2013
BS MPH 2013
BA 2008 MPH 2013
University of Washington
BK Virus and Long- Internal Medicine
term Renal
Resident, Virginia
Complications in
Mason, Seattle,
Cord Blood
WA
Transplant Recipients
*IDSA Medical Scholars Program Award 2010 Recipient
Università Vita-Salute San Raffaele, Milan, Italy
CMV in D- Pediatric Infectious Disease
Transplant
Consultant,
Recipients; CMV
Ospedale
Reactivation in
Niguarda Cà
Patients Receiving Granda, Milan
Imatinib; CMV PCR in
the Diagnosis of CMV
Pneumonia in HCT
Carroll College, Helena, MT
Epidemiology,
2nd year Psychiatry
Outcomes and
Resident. Pisgah
Treatment for
Institute, Asheville,
Pulmonary VRE in NC
Hematopoietic Cell
Transplant Recipients
DVM, Mich State Univ, East Lansing, MI MPH, University of Washington
Viridans Streptococcal Infections in Hematopoietic Cell Transplant Patients
Senior Lecturer, Institute of Vet, Animal & Biomedical Sciences, Massey University, New Zealand
University of Washington
1) Infectious Complications in Single and Double Cord Blood Transplant Recipients, 2) Surveillance Cultures
Hem/Onc Fellow University of Washington
*IDSA Medical Scholars Program Award 2010 Recipient
BS, Rice Influenza vaccine in HIV Program
University, cancer patients and Associate, Clinton
Houston, TX caregivers / Nutrition Health Access
MPH,
practices among HCT Initiative, Phnom
University of recipiets
Penh, Cambodia
Otago, New
Zealand
Indiana
Foodborne Bacterial
University, Infections in
Bloomington, Hematopoietic Cell
IN
Transplant
Recipients; Novel
Viral Pathogens and
Pergam, SA - CV Page 8
Current Arianna Miles Pre (FHCRC)
Past Maresa
Pre
Woodfield
(FHCRC)
Past Zach
Pre
Stednick
(FHCRC)
Past Stephanie
Pre
Tse
(FHCRC)
Past
Sara
Post
Podczervinski
(SCCA)
Past
Shobini Sivagnanam (FHCRC)
Post
2013 2016
2013
2013 2013 20112015
2014 2017
Diarrheal Illness after Hematopoietic Cell Transplantation and Cancer Treatment
BS 2011 MPH 2014
Univ. of Michigan, Ann Arbor, MI Univ. of Washington, School of Public Health, Seattle, WA
Nasal screening for PhD-Candidate, methicillin-resistant UW Epidemiology Staphylococcus aureus (MRSA) on the SCCA transplant service; Levofloxacin resistance and GNR infections in Allogeneic Transplant Recipients
BS 2016
University of Lactobacillus
3rd Year Medical
Washington Bacteremia in HCT Student, University
Recipients, Marijuana of Washington,
use in Cancer and School of Medicine
Transplant Patients,
Measles in Cancer
Patients
*IDSA Medical Scholar
Awardee
*Mary Gates Research
Scholarship
MPH 2009
Johns Hopkins, Baltimore, MD
Influenza vaccine in Cancer Center employees
Database Manager, Kent School District
PharmD 2013
University of California, San Diego, PharmD
Vancomycin-overuse Clinical
in coagulase-negative Pharmacist,
staphylococci
Hematology
bacteremia
Oncology,
Stanford University
RN, MPH Western Michigan University (RN) University of Michigan (MPH)_
Influenza vaccination among staff at large cancer center
Program Manager, HealthcareAssociated Infections, WA State Department of Health, Shoreline, WA
BSc MBBS 2005
University of New South Wales
Legionella in
Director,
immunocompromised Microbiology
patients; Mucorales Department, The
cluster in Leukemia Children's Hospital
and HCT recipients; at Westmead,
Master of Medicine Westmead,
(Clinical Epi),
Australia
University of Sydney;
*Recipient of the Royal
Australasian College of
Physicians 2015 Joseph
Thornton Tweddle
Research Entry
Scholarship
Pergam, SA - CV Page 9
Current Kerry McMillen (SCCA)
Past Hafiz Aslam (FHCRC)
Past
Kevin Celustka (FHCRC)
Past
Trenton MacAllister (SCCA)
Post Pre Pre Pre
2014-
20152016 2016-
20162018
MS, RD, CSO, CD
Body Mass and Glucose Control in Post-HCT recipients; Nutritional habits of post-transplant patients
Clinical Nutrition Supervisor, SCCA;
*Oncology Nutrition Small Research Grant Recipient
MBBS 1998 MPH 2017
Allama Iqbal Medical College, Lahore, Pakistan
Assessing Patient Knowledge of Isolation Practices in Cancer Patients
MPH-graduate, North Dakota State University
BS University of Nutrition and the Gut Sales Strategy &
Washington, Microbiome,
Operations Analyst
BA
Improving Psychiatric LinkedIn, San
Engagement in
Francisco, CA
Cancer patients,
*Selected as Summer
Undergraduate Research
Program, FHCRC
MS 2015 MPH 2017
Georgetown University, Washington, DC
Norovirus in Transplantation, VRE in HCT
Infection Preventionist, StLuke's Hospital, Boise, Idaho
Past Steven
Pre
Roncaioli
(SCCA)
Past Erica Stohs Post (FHCRC)
Current Andrea Sosa Pre (SCCA)
20172019
20162018
20182019
BS 2016 MPH 2018
University of Connecticut
Breakthrough Pneumocystis Cases in Hematology Oncology
Infection Control Practitioner, BronxLebanon Hospital, New York, NY
MD 2012 University of Surveillance Blood Nebraska cultures in HCT
Assistant Professor, Division of Infectious Diseases, University of Nebraska
BS, 2015
Universidad Tuberculosis
MPH-Candidate,
San
Screening among Michigan State
Francisco de Hematopoietic Cell University School
Quito
Transplant Recipients of Public Health,
Quito,
Lansing, MI
Ecuador
Current Margaret Lind Pre (FHCRC)
Current John
Pre
Masembe
(SCCA)
20182019-
BS 2012 MPH 2017
Western
Machine learning and
Washington sepsis in cancer and
University transplant patients
(BS) UW. *ITHS TL1 Recipient
School of 2019-2020
Public Health
(MPH)
PhD-candidate, Epidemiology, University of Washington School of Public Health
BS University of candidate Washington
Bothell, Seattle, WA
Cancer caregivers and vaccination beliefs
undergraduate student
Pergam, SA - CV Page 10
Current
Mirta MaravillaRosas (FHCRC)
Current Paula Marsland (FHCRC)
Current Tomiteru Togano (FHCRC)
Pre 2019-
BS Saint
Neurologic
Hutch IDS summer
candidate Martin's
assessment in sepsis intern,
University,
undergraduate
Lacey, WA
student
Pre 2019-
MD- University of Strep viridans sepsis MS-3, University of
Candidate Washington in cancer patients, Washington
School of emergence of
School of Medicine
Medicine Levofloxacin
resistance
Post 2019-
MD National
Radiation exposure Department of
Center for related to fungal
Hematology,
Global
infections in HCT
National Center for
Health and recipients
Global Health and
Medicine in
Medicine in Japan,
Japan,
Tokyo, Japan
Tokyo,
Japan
Graduate/Training Grant Committees
Past/ Current
Trainee
Pre/ Post Level
Year
Degree / Award Role
Past Past Past Past Past Past Past
Nicole Boyle
BS 20122014
Janelle Wierenga
DVM 20122013
Arianna Miles-Jay
BS 20132014
Trent McAllister
MS 20152016
Steven Roncaioli
MPH 20172018
Michelle Young
MBBS 2017-
Hannah Imlay MS 2018-
Current Chikara
MD
Ogimi
Current Margaret Lind MS
20162018-
MPH Epidemiology, Committee MPH Epidemiology, Committee MPH Epidemiology, Committee MPH Epidemiology, Committee MPH Epidemiology, Committee PhD Committee
MPH Epidemiology, Committee
K-Award Committee
PhD Committee
Current Elliot Lee
BS 2019- PhD Committee
School / Program
University of Washington, School of Public Health
University of Washington, School of Public Health
University of Washington, School of Public Health
University of Washington, School of Public Health
University of Washington, School of Public Health
Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
University of Washington, School of Public Health
Seattle Children's, Infectious Disease Fellowship Program
University of Washington School of Public Health, Department of Epidemiology University of Washington School of Medicine, Department of Microbiology
Pergam, SA - CV Page 11
12. EDITORIAL RESPONSIBILITIES 2014present Co-Section Editor, Transplant and Oncology, Current Infectious Disease Reports 2014present Associate Editor, Viral Diseases, BMC Infectious Diseases
13. SPECIAL NATIONAL RESPONSIBILITIES
20092010 20102011
20112013 2014present 2015
2015-present 2016-present
Independent Safety Monitor, NIH/NIAD, DMID Influenza Protocols: 09-0039,
09-0043, 09-0047, 09-0053, and 09-0054: H1N1
Independent Safety Monitor, NIH/NIAID, DMID Protocol 09-0002: Comparison of the Safety and Immunogenicity of Lyophilized IMVAMUNE® (1x108 TCID50) versus Liquid Formulation IMVAMUNE® (1x108 TCID50) Administered by the Subcutaneous Route and a Lower Dose Liquid Formulation IMVAMUNE® (2x107 TCID50) Administered by the Intradermal Route in Healthy Vaccinia-Naïve Individuals (Bavarian Nordic)
Member, Data and Safety Monitoring Board: Effect of tenofovir on genital HSV shedding: a randomized, double-blind, placebo-controlled, clinical trial
Member, Conference Committee, Association for Professionals in Infection Control and Epidemiology (APIC)
Co-Chair, Transplant Infectious Diseases Pre-Meeting Workshop, "Primer on Transplantation", Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/International Congress on Chemotherapy (ICC) Sept 17-21, 2015 San Diego, CA.
Member, Zoster Working Group, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention, Department of Health and Human Services
Member, Abstract Selection Committee, Association for Professionals in Infection Control and Epidemiology (APIC)
2016-present Member, Antimicrobial Stewardship and Cancer Consortium Committee
2016-present Member, Medical Advisory Board, The Bone Marrow Foundation
2016-present Altmetrics, Ambassador
2016-2017 2017-present
Independent Safety Monitor, NIH/NAID, DMID Protocol 16-0117: Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
NCCN Prevention and Treatment of Cancer-Related Infections Panel
2017-present The National Academies of Sciences, Engineering and Medicine Committee on Management of Legionella in Water Systems
2017-present American Society of Blood and Marrow Transplant, Infectious Diseases Practice Guidelines Committee
2018-present International Council Member, Immunocompromised Host Society
2020-present ID Week Program Committee (IDWPC)
2019
Ad hoc reviewer: Acta Haematologica, Antiviral Therapy, American Journal of Infection Control, American Journal of Transplantation, Antimicrobial Resistance & Infection Control, Biology of Blood and Marrow Transplant, Brazilian Journal of Infectious Diseases, CA journal, Cancer, Cannabis and Cannabinoids, Clinical Infectious Diseases, Emerging Infectious Diseases, European Journal of Cancer Care, Expert Review of Vaccines, Journal of Antimicrobial Therapy, Journal of Hospital Infection, Journal of Oncology Practice
Pergam, SA - CV Page 12
14. SPECIAL LOCAL RESPONSIBILITIES
20012005 20012005
20032005 2009
2009present 2009present 2010present 20102012 2011present 2012 & 2016 20122015 2012-present 2013-present 2013-present 2014-2015 2014-2015 2014-2015 2014-2015 2014-present 2014-present 2014-present 2014-present 2015-present 2015-present 2016
2016-present 2016-2017 2017-2018 2016-present 2017 2017- present 2017- present 2018 2018 2019
Member, Internal Medicine Post Graduate Committee, University of New Mexico Member, Internal Medicine Residency Recruitment Committee, University of New Mexico Member, Education Task Force, University of New Mexico Member, Annual Research Conference Committee, Vaccine and Infectious Diseases Division (VIDD), Fred Hutchinson Cancer Research Center (FHCRC) Chair, Infection Control Committee, Seattle Cancer Care Alliance (SCCA) Chair, Infectious Diseases Clinical Care Conference, FHCRC Member, Standard Practice Committee, Infectious Diseases Representative, SCCA Co-Chair, Infections in Cord Blood Transplant Working Group, FHCRC Member, Institutional Biosafety Committee, FHCRC Reviewer, ITHS Small Pilot Grant Submissions Member, ITRAP & HIDRA Committee, FHCRC Member, Pharmacy and Therapeutics Subcommittee, UW/SCCA Member, Executive Quality Committee, SCCA Member, Medical Executive Committee, SCCA Member, Ebola Virus Disease Ambulatory Workgroup, UW Chair, Ebola Preparation Committee, SCCA Member, Ebola Preparation Steering Committee, UW Member, Ebola Education Committee, HMC Member, Chemo / ID Pathway Working Group, UW Member, Infection Control Committee, UW Member, C. diff Steering Committee, UW Mentor, Hutch United Member, Biostatistics Shared Resources (BSR) Advisory Group, FHCRC Co-Chair, Water Management Committee, SCCA Member, Search Committee, Outpatient Antibiotic/Antimicrobial Treatment Program Faculty Position, FHCRC & SCCA UWMC CLABSI Prevention Committee, UW Member, Search Committee, Gastroenterology Faculty Position, FHCRC Member, Search Committee, Microbiome Faculty Position, FHCRC Member, Medical Leadership Development Work Group, SCCA Member, Organizing Committee, Hutch United Inclusivity Workshop Co-Chair, Infectious Diseases in the Immunocompromised Affinity Group/Lecture series Medical Advisor, Prevention Center Oversight Committee
Member, VIDD Faculty Retreat Planning Committee Member, Infections in Immunocompromised Host Symposium Committee Co-Chair, Flu Symposium, FHCRC
15. RESEARCH FUNDING
Current:
Washington Vaccine Alliance (WAVA) Pilot Award (PI: S. Pergam)
10/1/13-6/30/20
Interactions between gastrointestinal microbiota, Influenza vaccine responses and respiratory viral
infections in a large cohort of clinic employees
Pergam, SA - CV Page 13
Private Donation
(PI: S. Pergam)
Patterns in Nutrition and Transplant Aftereffects (PINATA)
3/1/14-2/28/20
BAA-NIAID-DMID-NIH-AI
(PI: M. Ison; Subcontract PI: Pergam) 5/1/16-4/30/20
Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and
Chronic Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
1U01AI132004-NIAID
(PI: N.Halasa; Subcontract PI: Pergam) 7/5/2017-6/30/20
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
1R01AI134808-NIAID
(PI: D. Fredricks)
The Gut Microbiota and Graft-Versus-Host-Disease (GVHD)
11/6/17-11/31/22
IR 10087 RG1004525
(PI: Steven Pergam)
9/5/18-9/5/20
Prevention of REspiratory Viruses using NOzin® in StEm Cell Transplant Recipients (PREV-NOSE
study)
Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) Study
(PI: A Freifeld)
07/01/17-07/01/20
FY20 VIDD Faculty Initiative Award Fecal Microbiota Transplantation for Graft-Versus-Host Disease
(PI: D. Fredricks, S. Pergam)
07/01/19-6/30/20
Completed:
UNM Research Allocation Committee Grant (PI: S. Pergam) Long term Consequences of West Nile Virus (WNV) Infection
7/10/04-6/30/05
NIH/NIAID T32 AI007-044
(PI: W. Stamm)
Host Defense Training in Allergy and Infectious Diseases
Seattle Genetics, Inc. Research Grant (PI: S. Pergam) Infections in Autologous Transplant Recipients
9/1/05-2/1/07 10/1/10-4/30/11
ASBMT New Investigator Award (PI: S. Pergam)
7/1/09-6/30/13
Natural Killer Subtypes and CMV Reactivation in Hematopoietic Cell Transplantation
K23 (KHL096831-02) NHLBI
(PI: S. Pergam)
8/20/09-6/30/14
Natural Killer Cell Receptor Diversity and CMV in Hematopoietic Cell Transplantation
VIDD Faculty Initiatives Award
(PI: S. Pergam)
10/24/12-6/30/14
The Role of Gastrointestinal Microbiota in Graft-Versus-Host-Disease and Post-Transplant Infections
VIDD Faculty Initiatives Award
(Co-PI: S. Pergam, Co-PI: J. Sugimoto) 7/1/15-6/30/16
Developing Models of Respiratory Viral Outbreaks in Immunosuppressed Cancer and Transplant
Patients
Industry Sponsored Clinical Trials:
Chimerix, Inc.
(PI: Pergam)
2016-current
An Intermediate-size, Expanded Access Protocol to Provide Bincidofovir for the Treatment of Serious
Adenovirus Infection or Disease, Protocol CMX001-35" 6/17/2017-present
Prior Industry Trials Merck, Sharp & Dohme Co., Inc
(PI: Pergam)
2012-2015
Pergam, SA - CV Page 14
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCT)
Cubist Pharmaceuticals, Inc.*
(PI: Pergam)
2013-2015
A Phase IIIb, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study to Demonstrate the
Safety & Efficacy of Fidaxomicin for Prophylaxis against C difficile-Associated Diarrhea in Individuals
Undergoing Hematopoietic Cell Transplants (HCT) *formerly Optimer pharmaceuticals
Chimerix, Inc.
(PI: Pergam)
2016
A Multicenter Non-Interventional Study to Obtain Retrospective Data for Subjects Previously
Diagnosed with Adenovirus Infection to serve as Matched Historical Controls for Study CMX001-304;
Protocol No. CMX001-305
Chimerix, Inc.
(PI: Pergam)
2015 - 2017
A Phase 3, Open-label, Multicenter Study of the Safety/Tolerability and Efficacy of Brincidofovir
(CMX001) for the Prevention of Adenovirus (AdV) Disease in Subjects with Asymptomatic AdV
Infection at Risk of Progression and for the Treatment of Subjects with Localized or Disseminated
AdV Disease
16. BIBLIOGRAPHY (ORCID ID: 0000-0002-6333-5196 / Researcher ID: C-2286-2008)
A. Publications in Refereed Journals ( = contributed equally, *highlighted papers)
1. Pai, RK, Pergam, SA, Kedia, A, Cadman, CS, Osborn, LA. A rare cause of pacemaker lead infection secondary to Haemophilus parainfluenzae. PACE. 2004;27:1008-1010. PMID: 15271026. [Case]
2. Haaland K, Sadek J, Pergam S, Echevarria L, Davis L, Goade D, Harnar J, Nofchissey RA, Sewell M, Ettestadt P. Mental status after West Nile virus infection. Emerg Infect Dis. 2006 Aug;12(8):12602. PMID: 16965710. [Original Work]
3. Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL. West Nile virus neuroinvasive disease. Ann Neurol. 2006 Sep;60(3):286300. PMID: 16983682. [Review]
4. Pergam SA, Echevarria L, DeLong CE, Scully G, Goade DE. Myocarditis in West Nile virus infection. Am J Trop Med Hyg. 2006 Dec;75(6):1232-3. PMID: 17172398. [Original]
5. Pergam SA, Wang CC, Gardella CM, Sandison TG, Phipps WT, Hawes SE. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol. 2008 Jul;199(1):38.e1-9. PMID: 18486089; PMCID: 2517631. [Original]
6. O'Connor KM, Williams P, Pergam SA. An unusual case of knee pain: pseudogout and Abiotrophia defectiva infection. South Med J. 2008 Sep;101(9):961-2. PMID: 18708985; PMCID: 2735253. [Case]
7. Buskin SE, Ellis GM, Pepper GG, Frenkel LM, Pergam SA, Gottlieb GS, Horwitch C, Olliffe JF, Johnson K, Shalit P, Heinen C, Schwartz M, Wood RW. Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):205-11. PMID: 18769347; PMCID: 2586929. [Original]
8. Pergam SA, Schmidt DW, Nofchissey RA, Hunt WC, Harford AH, Goade DE. Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg. 2009 Feb;80(2):279-85. PMID: 19190227. PMCID: 2706524. [Original]
9. Sadek J, Pergam SA, Harrington JA, Echevarria LA, Davis LE, Goade D, Harnar J, Nofchissey RA, Sewell MC, Ettestad P, Haaland KY. Persistent neuropsychological impairment associated with West Nile Virus. J Clin Exp Neuropsychol. 2009 Jun 8:1-8. PMID: 19513920 [Original]
10. Englund J, Zerr D, Heath J, Pergam S, Kuypers J, Yager J, Boeckh M, Mattson D, Whittington N, Whimbey E, Duchin J, Uyeki T, Deyde V, Sheu T, Trujillo A, Klimov A, Gubareva L, M Kay. Oseltamivir-Resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients
Pergam, SA - CV Page 15
Seattle, Washington, 2009. Morb and Mort Weekly Report. 2009 Aug 21;58(32):893-6. PMID: 19696719 [Original]
11. Travi G, Pergam SA, Xie H, Carpenter P, Kiem HP, Corey L, Boeckh MJ. The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation. Clin Infect Dis. 2009 Dec 1;49(11):e120-3. doi: 10.1086/648120. PMID: 19886798; PMCID: 2779734. [Original]
12. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror M, Boeckh M, Martin PJ, Sandmaier BM, Marr K, Appelbaum FR, Storb R, McDonald GB. Reduced mortality after allogeneic hematopoietic cell transplantation. N Engl J Med. 2010; 363: 2091 - 2101. PMID: 211055791; PMCID: 3017343. [Original]
13. Renaud C, Pergam SA, Polyak C, Jain R, Kuypers J, Englund JA, Corey L, Boeckh MJ. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir. Transpl Infect Dis. 2010 Dec;12(6):513-7. PMID: 21062390; PMCID: 3024056. [Case]
14. Pergam SA, Forsberg C, Boeckh M, Maynard C, Limaye A, Wald A, Young B. Herpes Zoster incidence in a multi-center cohort of solid organ transplant recipients. Transpl Infect Dis. 2011 Feb;13(1):15-23. PMID: 20636480; PMCID: 2976841. [Original]
15. Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood. 2011 Nov 17;118(20):5689-96. PMID: 21937692; PMCID: 3217367. [Original]
16. Milano F, Chien JW, Riffkin I, Gutman JA, Newell L, Pergam SA, Delaney C. Stable long-term pulmonary function after myeloablative double cord blood transplant. Biol Blood Marrow Transplant. 2012 Feb;18(2):309-13. PMID: 21840290; PMCID: 3258377. [Original]
17. Florescu D, Pergam SA, Neely M, Johnston C, Way SS, Sande J, Lewinsohn D, Guzman, Cottrill J, Kurtzberg J, Papanicolaou G, Graham ML, Painter W, Lanier R, Mommeja-Marin H, van der Horst C. Safety and efficacy of CMX001 as salvage therapy for severe Adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant. 2012 May;18(5):731-8 PMID: 21963623; PMCID: 3608125. [Original]
18. Martin PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan K, Storer BE. Evaluation of oral Beclomethasone Dipropionate for prevention of acute graft-versus-host disease. Biol Blood Marrow Transplant. 2012 Jun;18(6):922-9. PMID: 22079469; PMCID: 3331897. [Original]
19. Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Stevens-Ayers T, Ilieva V, Kimball LE, Huang ML, Hayes TS, Corey L, Boeckh MJ. Risk factors and efficiency of CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012 Sep;18(9):1391-400. PMID: 22387334; PMCID: 3572857. [Original]
20. Green M, Leisenring W, Stachel D, Pergam SA, Sandmaier BM, Wald A, Corey L, Boeckh M. Efficacy of a viral load based, risk-adapted, preemptive treatment strategy for prevention of Cytomegalovirus (CMV) disease after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Nov;18(11):1687-1699. PMID: 22683614; PMCID: 3467354. [Original]
21. Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis. 2013 Oct;57(7):1001-4. PMID: 23759343; PMCID: 3765008. [Original]
22. Mullane K, Winston D, M Wertheim, Betts R, Poretz D, Camacho L, Pergam S, Sterling T, Zhao Y, Manoff S. Safety and immunogenicity of heat-treated Zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis. 2013 Nov 1;208(9):1375-85. PMID: 23908479. [Original]
23. Chu HY, Englund JA, Podczervinski S, Kuypers J, Campbell AP, Boeckh MJ, Pergam SA, Casper C. Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center. Biol Blood Marrow Transplant. 2014 Jun;20(6):844-51. PMID: 24607551; PMCID: 4036533. [Original]
24. Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary
Pergam, SA - CV Page 16
aspergillosis. Transpl Infect Dis. 2014 014 Jun;16(3):505-10. PMID: 24725139; PMCID: 4419737. [Original]
25. Travi G, Pergam SA. Cytomegalovirus Pneumonia in Hematopoietic Stem Cell Recipients. J Intensive Care Med. 2014 Jul-Aug;29(4):200-12. doi: 10.1177/0885066613476454. Epub 2013 Feb 6. PMID: 23753231; PMCID: 3775875. [Review]
26. Kalapila A, Pergam SA, Pottinger P, Butler-Wu S, Whimbey E, Duchin J. Multi-drug Resistant Bacteroides fragilis Seattle, Washington. Morb and Mort Weekly Report. 2013 Aug 30; 62(34):694-6. [Original]
27. Boyle NM, Podczervinski S, Jordan K, Stednick Z, Butler-Wu SM, McMillen K, Pergam SA. Bacterial Foodborne Infections After Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014 2014 Nov;20(11):1856-61. PMID: 25020101; PMCID: 4194273. [Original]
28. *Miles-Jay A, Butler-Wu S, Rowhani-Rahbar A, Pergam SA. Incidence rate of fluoroquinolone resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplant patients during an era of levofloxacin prophylaxis. Biol Blood Marrow Transplant. 2015 Mar;21(3):539-45. doi: 10.1016/j.bbmt.2014.12.006. Epub 2014 Dec 11. PMID: 25498393; PMCID: PMC4329069 [Original]
29. Salipante SJ, Kalapila A, Pottinger PS, Hoogestraat DR, Cummings L, Duchin JS, Sengupta DJ, Pergam SA, Cookson BT, Butler-Wu SM. Characterization of a multidrug-resistant, novel bacteroides genomospecies. Emerg Infect Dis. 2015 Jan;21(1):95-8. doi: 10.3201/eid2101.140662. PMID: 25529016; PMCID: PMC4285247. [Case]
30. Miles-Jay A, Podczervinski S, Stednick Z, Pergam SA. Evaluation of routine pre-transplant screening for Methicillin-resistant Staphylococcus aureus in hematopoietic cell transplant recipients. Am J Infect Control. 2015 Jan 1;43(1):89-91. PMID: 25564131; PMCID: 4286793. [Original]
31. Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood. 2015 Mar 12;125(11):1724-9. pii: blood-2014-12-616516. PMID: 25593338; PMCID: PMC4357580. [Original]
32. Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Comparison of "Carrot-vs.-Stick" approaches to employee influenza vaccination in a large cancer center with high baseline compliance rates. Am J Infect Control. 2015 Mar 1;43(3):228-33. doi: 10.1016/j.ajic.2014.11.025. PMID: 25728148; PMCID: 4372134. [Original]
33. Pergam SA. Addressing Fear, Fighting Complacency. Clin Pharmacol Ther. 2015 Oct;98(4):359-61. doi: 10.1002/cpt.162. PMID: 26095023. [Editorial]
34. Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JW, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C; Blood and Marrow Transplant Clinical Trials Network Trial 0201. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant. 2016 Feb;22(2);359-370. doi: 10.1016/j.bbmt.2015.09.013. PMID: 26409243. PMCID: 4716871 [Original]
35. Boyle NM, Magaret A, Stednick Z, Morrison A, Butler-Wu S, Zerr D, Rogers K, Podczervinski S, Cheng A, Wald A, Pergam SA. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015 Oct 14;4:41. doi: 10.1186/s13756-015-0081-4PMID: 26473030; PMCID: 4606905. [Original]
36. Pergam SA. Infection Prevention in Transplantation. Curr Infect Dis Rep. 2016 Jan;18(2):7. doi: 10.1007/s11908-015-0513-6. PMID: 26820654 [Review]
37. Sivagnanam S, Pergam SA. Legionellosis in Transplantation. Curr Infect Dis Rep. 2016 Mar;18(3):9. doi: 10.1007/s11908-016-0517-x. PMID: 26857395 [Review]
38. Cohen S, Woodfield M, Boyle N, Stednick Z, Boeckh M, Pergam SA. Incidence and Outcomes of Bloodstream Infections among Hematopoietic Cell Transplant Recipients from Species Commonly
Pergam, SA - CV Page 17
Reported to be in Over-the-Counter Probiotic Formulations. Transpl Infect Dis. 2016 Oct;18(5):699705. doi: 10.1111/tid.12587. PMID: 27501401. PMCID: 5160044. [Original]
39. Cheng G-S, Stednick Z, Madtes D, Boeckh M, McDonald GB, Pergam SA. Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients in an Era of Improved Diagnostics and Empirical Therapy. Biol Blood Marrow Transplant. 2016 Dec;22(12):2243-2249. doi: 10.1016/j.bbmt.2016.08.023. PMID: 27590103. [Original]
40. Sahoo F, Hill JA, Xie H, Leisenring W, Yi J, Goyal S, Kimball LE, Lee I, Seo S, Davis C, Pergam SA, Flowers MED, Liaw K-L, Holmberg L, Michael Boeckh M. Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies. Biol Blood Marrow Transplant 2017 Mar;23(3):505-511. doi: 10.1016/j.bbmt.2016.12.620. PMID: 28039754. [Original]
41. Mazengia E, Kawakami V, Rietberg K, Kay M, Wyman P, Skilton C, Aberra A, Boonyaratanakornkit J, Limaye A, Pergam SA, Whimbey E, Olsen R, Duchin JS. A Hospital-Acquired Listeriosis Linked to Milk Shakes from a Soft Serve Ice Cream Machine That Was Contaminated a Year Earlier. Epidemiol Infect 2017 Apr;145(5):857-863. doi: 10.1017/S0950268816003198. PMID: 28065212 [Original]
42. Boeckh M, Stevens-Ayers T, Travi G, Huang ML, Cheng GS, Xie H, Leisenring W, Erard V, Seo S, Kimball L, Corey L, Pergam SA, Jerome KR. Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation. J Infect Dis. 2017 Apr;145(5):857-863. doi: 10.1093/infdis/jix048. [Epub ahead of print]. PMID: 28181657 [Original]
43. Pergam SA. Fungal Pneumonias in Patients with Hematologic Malignancies and Those Undergoing Hematopoietic Cell Transplantation. Clin Chest Med. 2017 Jun;38(2):279-294. doi: 10.1016/j.ccm.2016.12.006. PMID: 28477639. [Review]
44. MacAllister T, Stednick Z, Golob J, Huang ML, Pergam SA, Under-utilization of norovirus testing in hematopoietic cell transplant recipients at a large cancer center, Am J Infect Control. 2018 Jan:46(1):100-102. doi: 10.1016/j.ajic.2017.06.010. [Epub ahead of print] PMID: 28757083 [Original]
45. Xue KS, Stevens-Ayers T, Campbell AP, Englund JA, Pergam SA, Boeckh M, Bloom JD. Parallel evolution of influenza across multiple spatiotemporal scales. eLife. 2017 Jun 27;6. doi: 10.1111/tid.12745. PMID: 28653624 [Original]
46. *Sivagnanam S, Podczervinski S, Butler-Wu SM, Hawkins V, Stednick Z, Helbert LA, Glover WA, Whimbey E, Duchin J, Cheng GS, Pergam SA. Legionnaires' disease in transplant recipients: A 15year retrospective study in a tertiary referral center. Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12745. PMID: 28696077 [Original]
47. Chin A, Pergam SA, Fredricks D, Hoofnagle A, Baker K, and Jain R [AAC00569-17R1], Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High-Risk for Fungal Infections, Antimicrobial Agents and Chemotherapy 2017 Sep 22;61(10). pii: AAC.00569-17. doi: 10.1128/AAC.00569-17. PMID: 28760896 [Original]
48. Golob J, Pergam SA, Srinivasan S, Fiedler TL, Liu C, Garcia K, Mielcarek M, Ko D, Aker S, s S, Loeffelholz T, Plantinga A, Wu MC, Celustka K, Morrison A, Woodfield M, Fredricks DN. The Stool Microbiota at Neutrophil Recovery is Predictive for Severe Acute Graft vs. Host Disease After Hematopoietic Cell Transplantation. Clinical Infectious Diseases 2017 Nov 29;65(12):1984-1991. doi: 10.1093/cid/cix699. PMID: 29020185 [Original]
49. *Pergam SA, Woodfield M, Lee CM, Cheng GS, Baker K, Marquis S, Fann JR Cannabis Use among Patients at a Comprehensive Cancer Center in a State with Legalized Medicinal and Recreational Use. Cancer. 2017 Nov 15;123(22):4488-4497. doi: 10.1002/cncr.30879. PMID: 28944449 [Original]
50. *Sivagnanam S, Sengupta DJ, Hoogestraat D, Jain R, Stednick Z, Fredricks DN, Hendrie P, Whimbey E, Podczervinski ST, Krantz EM, Duchin JS, Pergam SA. Seasonal clustering of sinopulmonary Mucormycosis in patients with hematologic malignancies at a large comprehensive cancer center. Antimicrob Resist Infect Control. 2017 Dec 6;6:123. doi: 10.1186/s13756-017-0282-0. PMID: 29225797 PMC: 5718160 [Original]
Pergam, SA - CV Page 18
51. Bhattacharyya A, Hanafi LA, Sheih A, Golob JL, Srinivasan S, Boeckh MJ, Pergam SA, Mahmood S, Baker KK, Gooley TA, Milano F, Fredricks DN, Riddell SR, Turtle CJ. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018 Feb;24(2):242-251. doi: 10.1016/j.bbmt.2017.10.003. PMID: 29024803 [Original]
52. Stohs E, MacAllister T, Pergam SA, Krantz E, Jain R, Sweet A, Liu C. Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogenic Hematopoietic Cell Transplant Recipients. Infect Control Hosp Epidemiol. 2018 Jun;39(6):730-733. doi: 10.1017/ice.2018.43. PMID: 29589825 [Original]
53. *MacAllister T, Stohs E, Lui C, Bryan A, Whimbey E, Phipps A, Pergam SA.10-year trends in vancomycin-resistant Enterococci among allogeneic hematopoietic cell transplant recipients. Journal of Infection. 2018 Jul;77(1):38-46. doi: 10.1016/j.jinf.2018.02.014. PMID: 29746941 [Original]
54. Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Zák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Ivan SF, Chan P, Kaplan SS, Parrino J, Lee I, Zoran Popmihajlov Z, Annunziato PW, Arvin A. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018 May 26;391(10135):2116-2127 PMID: 29856344 [Original]
55. Hill J, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, Delaney C, Milano A Modified Intensive Strategy to prevent CMV disease in Seropositive Umbilical Cord Blood Transplant Recipients. Biol Blood Marrow Transplant. 2018 doi: 10.1016/j.bbmt.2018.05.008. PMID: 29753836 [Original]
56. Ogimi C, Krantz E, Golob J, Waghmare A, Liu C, Leisenring WM, Woodard C, Marquis S, Kuypers J, Jerome K, Pergam SA, Fredericks DN, Sorror ML, Englund JA, Boeckh M. Antibiotic exposure prior to respiratory viral infection is associated with progression to lower respiratory tract disease in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2018 No: 24(11)2293-2301. doi: 10.1016/j.bbmt.2018.05.016. PMID: 2977867 [Original]
57. Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS. A Randomized, Placebo-Controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile Associated Diarrhea in Adults undergoing Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases. 2019. 68(2):196-203. doi: 10.1093/cid/ciy484. PMID: 29893798 [Original]
58. Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR 3rd, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen MH. How clean is the hospital linen at my hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers. Clinical Infectious Diseases. 2018 doi: 10.1093/cid/ciy669 PMID:30299481 [Original]
59. Price S, Podczervinski S, MacLeod K, Helbert L, Pergam SA. Understanding Influenza Vaccination Rates and Reasons for Refusal in Caregivers and Household Contacts of Cancer Patients. Am J Infect Control. 2018 https://doi.org/10.1016/j.ajic.2018.10.010 PMID:30522836 [Original]
60. Stohs E, Chow VA, Liu C, Bourassa L, Miles-Jay A, Knight J, Sweet A, Storer BE, Mielcarek M, Pergam SA. Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease. Biol Blood Marrow Transplant Biol Blood Marrow Transplant. 2019 Jun;25(6):1247-1252. doi: 10.1016/j.bbmt.2019.01.031. Epub 2019 Feb 1. PMID: 30711778
61. Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto J, Dadwal S, Freifeld A, Jain R, Pergam SA, Tverdek FP, Seo S. Antimicrobial Stewardship in Cancer Patients: The Time is Now. J Natl Compr Canc Netw. 2019 Jul 1;17(7):772-775. doi: 10.6004/jnccn.2019.7318. PMID: 31319394
62. Krantz E, Liu C, Pergam SA, Stohs E, Sweet A, Zier J, Klaassen J, Ogimi C, Antibiotic Prescribing and Respiratory Viral Testing for Acute Upper Respiratory Infections Among Adult Patients at an
Pergam, SA - CV Page 19
Ambulatory Cancer Center. Clin Infect Dis. 2019 May 16. pii: ciz409. doi: 10.1093/cid/ciz409. PMID: 31095276
63. Pergam SA, Englund JA, Kamboj M, Gans HA, Young JH, Hill JA, Savani B, Chemaly RF, Dadwal SS, Storek J, Duchin J, Carpenter P. Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant 8/5/2019 https://doi.org/10.1016/j.bbmt.2019.07.034 PMID: 31394271
64. Golob JL, DeMeules MM, Loeffelholz T, Quinn Z, Dame M, Silvestri SS, Wu MC, Schmidt TM,
Fiedler TL, Hoostal M, Mielcarek M, Spence J, Pergam SA, Fredricks DN. Butyrogenic Bacteria after
Acute Graft Versus Host Disease Associate with the Development of Steroid Refractory GVHD, Blood Advances 2019 Oct 8;3(19):2866-2869. doi: 10.1182/bloodadvances.2019000362. PMID: 31585950
65. Boonyaratanakornkit J, Vivek M, Xie H, Pergam SA, Cheng GS, Mielcarek M, Hill JA, Jerome KR, Limaye AP, Leisenring W, Boeckh M, Waghmare A. Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract with Hematopoietic Stem Cell Transplantation Journal of Infectious Diseases. 2019 Sep 21. pii: jiz470. doi: 10.1093/infdis/jiz470. PMID: 31541573
66. Imlay H, Krantz E, Stohs ES, Lan KF, Zier J, Kim HN, Rakita R, Limaye AP, Wald A, Pergam SA, Liu C. Reported Beta Lactam and Other Antibiotic Allergies in Solid Organ and Hematopoietic Cell Transplant Recipients Clinical Infectious Diseases. ciz1025, https://doi.org/10.1093/cid/ciz1025
67. McKay SL, Guo A, Pergam SA, Dooling K. Herpes Zoster Risk in Immunocompromised Adults in the US: A Systematic Review. Clin Infect Dis. 2019 Nov 2. pii: ciz1090. doi: 10.1093/cid/ciz1090. PMID: 31677266
68. Duong A, Sweet A, Jain R, Hill JA, Pergam SA, Boeckh M, Liu C. Clinically significant drug interaction: letermovir and voriconazole. Journal of Antimicrobial Chemotherapy, 2019 Dec 04. doi.org/10.1093/jac/dkz499 PMID: 31800049
69. Woodfield MC, Carpenter PA, Pergam SA. Shots, not Moonshots. JAMA Oncol. 2019 Dec 19. doi: 10.1001/jamaoncol.2019.4572 PMID: 3185258 (Editorial)
70. Kim NJ, Hyun TS, Pergam SA, Issaka RB. Disseminated adenovirus infection after autologous stem cell transplant. Transplant Infectious Disease. doi: 10.1111/tid.13238 (in press)
71. McDonald GB, Sandmaier B, Mielcarek M, Sorror M, Pergam SA, Cheng GS, Hingorani S, Boeckh M, Florwers MD, Lee SJ, Appelbaum FR, Storb R, Martin PJ, Schoch G, Gooley TA. Survival, NonRelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: 2003-2007 vs. 2013-2017 Cohorts. Annals of Internal Medicine. (in press)
B. Book Chapters
1. Pergam SA and Jerome K. "Viral Infections of the Immunocompromised Host." Lennette's Laboratory Diagnosis of Viral Infections, 4th Edition. Ed. Jerome KR. Informa Healthcare, New York, NY. pp. 458-474.
2. Pergam SA, Mattson D, Boeckh M. "Infections in Leukemia and Hematopoietic Stem Cell Transplantation." Leukemia and Related Disorders: Integrated Treatment Approaches. Eds. E Estey E and Appelbaum FR. Humana Press, New York, NY, 2011. pp. 309-365.
3. Hirsch HH, Pergam SA. "Human Adenovirus, Polyomavirus, and Parvovirus Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation." Thomas' Hematopoietic Cell Transplantation, 2 Volume Set, 5th Edition. Eds. Appelbaum FR, Forman SJ, Negrin RS, Blume KG. Wiley-Blackwell, West Sussex, UK, Feb 2016. (ISBN: 978-1-118-41600-6).
C. Published Books, Videos, Software, etc. none
1. National Academies of Sciences, Engineering, and Medicine. 2019. Management of Legionella in Water Systems. Washington, DC: The National Academies Press. https://doi.org/10.17226/25474.
2. WA Dept of Health: Legionella and Water System Management video series (Youtube)
Pergam, SA - CV Page 20
D. Other Publications (Letters to the Editor, Invited Manuscripts)
1. Pergam SA, Hawes SE, Gardella GM, Wang CC. HCV and pregnancy: is now the time for universal testing? (editorial) Future Virol. 2008;3(1):1-5. [Invited Review]
2. Travi G, Pergam SA, Xie H, Boeckh MJ. Donor CMV serostatus not predictive of relapse in D-/Rpediatric HCT. Biol Blood Marrow Transplant. 2009 Jun;15(6):758-60. PMID: 19450762. PMCID: PMC2699379. [Letter to the Editor]
4. Pergam SA, Limaye A, and the AST Infectious Diseases Community of Practice. Varicella Zoster Virus (VZV) in solid organ transplant recipients. Am J Transplant. 2009 Dec, Vol 9 (suppl 4): S108S116. PMID: 20070670. PMCID: PMC2919834. [Invited Review]
5. Pergam SA, Limaye AP; and the AST Infectious Diseases Community of Practice. Varicella zoster virus in solid organ transplantation. Am J Transplant. 2013 Mar;13 Suppl 4:138-46. PMID: 23465007. [Invited Review]
6. Pergam SA, Woodfield M, Lee CM, Cheng GS, Baker K, Marquis S, Fann JR Cancer, 2018 "Response to `The pot dealer state harms patients with cancer' " Cancer. 2018 May 15;124(10):22562257 [Reply to Letter to the Editor] PMID:29603196
7. Hill JA, Pergam SA, Boeckh M, Milano F. "Cytomegalovirus infection among cord-blood allogeneic transplantation recipients: low incidence of cytomegalovirus events without high-dose valacyclovir prophylaxis." Biol Blood Marrow Transplant. [Reply to Letter to the Editor] PMID: 29969748
8. Pergam SA, Limaye AP; Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. AST Infectious Diseases Community of Practice. Clin Transplant. 2019 Jun 4:e13622. doi: 10.1111/ctr.13622. PMID: 31162727 [Invited Review]
9. Pergam SA, Shadman M, "Influenza in the Air" Journal of Oncology Practice J Oncol Pract. 2019 Apr;15(4):185-186. doi: 10.1200/JOP.19.00144. PMID: 30970227
10. National Comprehensive Cancer Network.(2017. 2018, 2019) Prevention and Treatment of CancerRelated Infections Current Version 1.2019.available at https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf
Web-Based Publications
1. Pergam S, Rupali J, Wald A. Acute Varicella Zoster Infection. BMJ Point-of-Care 2016. www.pointofcare.bmj.com. (updates 2011, 2012, 2013, 2014, 2015 , 2016)
E. Submitted Publications: See Augmented CV
F. Abstracts (presenter underlined):
1. Echevarria L, Pergam S, Davis L, Sewell M, Ettestad P, Haaland K, Nofchissey R, Goade D. Persistence of Symptoms in West Nile Virus from the 2003 New Mexico Outbreak. American Federation of Medical Research, Western Regional Conference. Carmel, CA, February 2005. (Abstract 310 Oral)
2. Pergam S, Schmidt D, Glass G, Harford A, Goade D. Proteinuria in Survivors of Hantavirus Pulmonary Syndrome. American Federation of Medical Research, Western Regional Conference. Carmel, CA, February 2005. (Abstract 309 Oral)
3. Pergam S, Nofchissey R, Arguello S, Sewell C, Ettestad P, Echevarria L, Davis L, Goade D. Symptom Persistence in West Nile Virus: Data from the New Mexico Outbreak of 2003. American Society of Tropical Medicine and Hygiene. Washington, DC, December 2005. (Abstract 753 Poster)
4. Nofchissey R, Echevarria L, Young S, Sewell M, Pergam S, Davis L, Goade D. Analysis of IgM and IgG Antibody Index values to West Nile Virus in a Multi-variant sample set from New Mexico WNV survivors. American Society of Tropical Medicine and Hygiene. Washington, DC, December 2005. (Abstract 754 Poster)
5. Sadek J, Haaland K, Pergam S, Echevarria L, Davis L, Goade D, Nofchissey R, Arguello S, Ettestadt P, Sewell, M. West Nile Neuroinvasive Disease Produces Mild Chronic Cognitive Deficits.
Pergam, SA - CV Page 21
International Neuropsychological Society. Portland, OR, February 2007. (Session #9, Abstract 75 Oral)
6. Buskin S, Kahle EM, Horwitch CA, Pergam SA, Ellis GM, Frenkel LM, Pepper GG, Oliffe J, Wood RW. HIV Drug Resistance Surveillance in Seattle, WA Including Multi-Class Drug Resistance and a Cluster of Four Individuals with Highly Related Highly Resistant Virus. International Society of Sexually Transmitted Diseases Research. Seattle, WA, August 2007. (Abstract O-93 Oral)
7. Pergam S, Wang C, Gardella C, Sandison T, Phipps W, Hawes S. Adverse Maternal and Neonatal Outcomes Associated with Maternal Hepatitis C Infection in Pregnancy. IDSA 45th Annual Meeting. San Diego, CA, October 2007. (Abstract 342 Oral)
8. Goade D, Nofchissey R, Echevarria L, Pergam S, Young S, Ettestad P, Sewell C, Davis L. Long term IgM and IgG Index values to West Nile Virus in a Multi-variant sample set from New Mexico WNV Survivors. American Society of Tropical Medicine and Hygiene. Philadelphia, PA, November 2007. (Abstract 663 Oral)
9. Pergam SA, Strasser SI, Flowers ME, Sullivan KM, McDonald GM. Chronic Hepatitis C, Cirrhosis, and End Stage Liver Disease Among 30-Year Survivors of Bone Marrow Transplant. ASBMT / CIBMTR Tandem Meeting, San Diego, CA, February 2008. (Abstract 78 Oral)
10. Pergam SA, Strasser SI, Flowers ME, Sullivan KM, McDonald GM. Risk Factors for the Development of Cirrhosis in Patients Infected with HCV During Hematopoietic Cell Transplant. 2nd Annual Infections in Cancer Symposium. Houston, TX, February 2008. (Oral)
11. Pergam S, Erard V, Delaney C, Wald A, Corey L, Boeckh M. Varicella Zoster Virus CNS Disease in Hematopoietic Cell Transplantation: A Single Center Experience. 15th International Symposium on Infections in the Immunocompromised Host. Thessalonki, Greece, June 2008. (Abstract 47 Poster)
12. Pergam SA, Boeckh M, Maynard C, Forsberg C, Limaye A, Young B. Increased Risk of Herpes Zoster in a Multi-center Veteran's Affairs Healthcare System Cohort of Solid Organ Transplant Recipients. ICAAC 48th Annual / IDSA 46th Annual Meeting. Washington, DC, October 2008. (Abstract 1330 Oral)
13. Young B, Pergam S, Boeckh M, Forsberg C, Maynard C, Limaye A, Davis C. Long-term Evaluation of Survival among Solid Organ Transplants among Veterans from 1995-2007. American Society of Nephrology. Philadelphia, PA, November 2008. (Abstract 554850 Poster)
14. Travi G, Pergam S, Xie H, Leisenring W, Carpenter P, Kiem H, Corey L, Boeckh M. Does Imatinib Affect CMV Outcomes in Hematopoietic Cell Transplant? ICAAC 49th Annual Meeting. San Francisco, CA, September 2009 (Abstract 2760 Poster)
15. Travi G, Pergam S, Xie H, Huang M, Erard V, Corey L, Boeckh M. The Utility of CMV Viral Load in BAL Fluid of Hematopoietic Cell Transplant Recipients with CMV Pneumonia. ICAAC 49th Annual Meeting. San Francisco, CA, September 2009. (Abstract 2646 Oral)
16. Pergam S, Boeckh M, Hsu K, Dinges W, Gooley T, Malkki M, Spellman S, Petersdorf E. Donor KIR3DS1 is Associated with Less CMV Disease Following Unrelated Hematopoietic Cell Transplantation in High Risk Subjects. ICAAC 49th Annual Meeting. San Francisco, CA, September 2009 (Abstract 2351 Oral)
17. Milano F, Pergam S, Xie H, Gutman JA, Riffkin I, Newell LF, Boeckh MJ, Delaney C. Pre-Transplant Ganciclovir and High-Dose Acyclovir Decrease Incidence of CMV Reactivation in Seropositive UCBT Recipients. 8th Annual International Umbilical Cord Blood Transplantation Symposium. San Francisco, CA, June 2010. (Poster)
18. Travi G, Pergam S, Xie H, Stevens-Ayers T, Hayes T, Huang ML, Erard V, Boeckh M. Comparison of Current Standard Testing and PCR for the Diagnosis of CMV Pneumonia by Bronchoaveolar Lavage in HCT Recipients. 16th Annual Symposium on Infections in the Immunocompromised Host. Budapest, Hungary, June 2010. (Abstract P67 Poster)
19. Pergam S, Gooley T, Boeckh M, Marr K, Chien J, McDonald G. Decreased Incidence of Infectious Complications in Hematopoietic Cell Transplant Recipients in 2003-2007 Compared to those
Pergam, SA - CV Page 22
Transplanted in the Previous Decade 1993-1997. 16th Annual Symposium on Infections in the Immunocompromised Host. Budapest, Hungary, June 2010. (Abstract P20 Poster)
20. Mullane K, Winston D, Wertheim M, Betts R, Poretz D, Comacho L, Pergam SA, Sterling T, Zhao Y, Manoff S. Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised (IC) Adults. IDSA 48th Annual Meeting. Vancouver, BC, October 2010. (Abstract 1379 Poster)
21. Florescu D, Rigdon J, Pergam SA, Neely M, Johnston C, Way SS, Sande J, Lewinsohn D, GuzmanCottrill J, Kurtzberg J, Papanicolaou G, Graham ML, Painter W, Lanier R, Mommeja-Marin H, van der Horst C. Experience with CMX001, a Novel Antiviral Drug, for Adenovirus Infections In Immunocompromised Patients. IDSA 48th Annual Meeting. Vancouver, BC, October 2010. (Late Breaker Abstract 5007 Poster)
22. Milano F, Pergam SA, Xie H, Gutman J, Rifkin I, Chow V, Newell LF, Boeckh M, Delaney C. PreTransplant Ganciclovir and High-Dose Valacyclovir Prophylaxis Decrease Incidence of CMV Reactivation in High-risk Seropositive UCBT Recipients. American Society of Hematology 52nd Annual Meeting. Orlando, FL, December 2010. (Oral)
23. Chow V, Milano F, Delany C, Xie H, Pergam SA. Incidence of Invasive Fungal Infections in Umbilical Cord Blood Transplant Recipients. American Federation for Medical Research, Western Regional Meeting. Carmel, CA, January 2011. (Oral)
24. Pollack M, Leisenring W, Pergam S, Corey L, Boeckh M. Evaluation of a Novel Viral Load Based Surveillance Strategy for Prevention of Cytomegalovirus (CMV) Disease in Hematopoietic Cell Transplantation. ASBMT Annual Meeting. Honolulu, HI, February 2011. (Abstract 342 Poster)
25. Chow V, Milano F, Delaney C, Xie H, Pergam S. Epidemiology of Invasive Fungal Infections in Cord Blood Transplant Recipients. ASBMT Annual Meeting. Honolulu, HI, February 2011. (Abstract 341 Poster)
26. Peddi VR, Boeckh M, Pergam SA, Scigliano E, Adey DB, Brennan DC, Godkin S, Robertson AT, Painter W. CMX001 Was Well Tolerated and without Nephrotoxicity in Renal Transplant (RT) and Hematopoietic Stem Cell Transplant (HSCT) Recipients with BK Virus (BKV) Infection in a Prospective, Randomized, Double-Blind Study. American Society of Nephrology: Kidney Week. Philadelphia, PA, November 2011. (Abstract Late Breaker-PO3168 Poster)
27. Astigarraga C, Tabellini L, Pergam S, Bumgarner T, Fan W, Grogan B, Storer B, Boeckh M, Zhao LP, Hansen JA. Latent CMV and the CD4+ T-Cell Transcription Program in Patients with Chronic GVHD. ASBMT / CIBMTR Tandem Meeting. San Diego, CA, February 2012. (Abstract 453 Poster)
28. Seo S, Kimball L, Xie H, Weiss A, Dahlgren C, Davis C, Boeckh M, Pergam SA. Infections Following Autologous Stem Cell Transplantation for Hodgkin's Lymphoma. ASBMT / CIBMTR Tandem Meeting. San Diego, CA, February 2012. (Abstract 138 Poster)
29. Fisher CE, Stevens AM, Leisenring W, Boeckh M, Pergam SA, Hohl TM. Bronchoalveolar lavage galactomannan testing contributes significantly to the diagnosis of invasive pulmonary aspergillosis and is not affected by mold-active therapy. 17th Annual Symposium on Infections in the Immunocompromised Host. Genoa, Italy, June 2012. (Oral)
30. Fisher CE, Stevens AM, Boeckh M, Leisenring W, Pergam SA, Hohl TM. Bronchoalveolar Lavage Galactomannan Testing Contributes Significantly to the Diagnosis of Invasive Pulmonary Aspergillosis and is not Affected by Mold-Active Therapy. IDWeek. San Diego, CA, October 2012. (Abstract 1300 Oral)
31. Fisher CE, Boeckh MJ, Leisenring W, Pergam SA, Hohl TM. The Serum Galactomannan Index Predicts Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Probable Pulmonary Invasive Aspergillosis. ASBMT / CIBMTR Tandem Meeting. Salt Lake City, UT, February 2013. (Abstract 358 Poster)
32. Boyle N, Podczervinski S, Jordan K, Stednick Z, Butler-Wu S, McMillen K, Pergam SA. Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients. ASBMT / CIBMTR Tandem Meeting. Salt Lake City, UT, February 2013. (Abstract 294 Poster)
Pergam, SA - CV Page 23
33. Cheng GS, Stednick Z, Madtes DK, McDonald GB, Boeckh MJ, Pergam SA. Changing Trends in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplant Recipients. ASBMT / CIBMTR Tandem Meeting. Salt Lake City, UT, February 2013. (Abstract 297 Poster)
34. Stednick Z, Podczervinski S, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Outcomes of "Carrot-vs.-Stick" Approaches to Employee Influenza Vaccination in a Large Cancer Center with High Baseline Compliance Rates. ID Week. San Francisco, CA, October 2013. (Abstract 400 Poster)
35. Campbell T, Stednick Z, Casper C, Cheng GS, Podczervinski S, Butler-Wu S, Pergam SA. Clinical Correlates of VRE Detection from the Lower Respiratory Tract among Hematopoietic Cell Transplant Recipients. ID Week. San Francisco, CA, October 2013. (Abstract 1530 Poster)
36. Podczervinski S, Spitters C, Helbert L, Madtes D, Cheng GS, Kelimoff N, Westburg A, Eaton K, Narita M, Pergam SA. Changes in Mycobacterium tuberculosis Epidemiology at a Large Cancer Center: Development of a Pre-Arrival Screening Strategy for Exposure Control. ID Week. San Francisco, CA, October 2013 (Abstract 1547 Poster)
37. Woodfield M, Boyle N, Stednick Z, Boeckh M, Pergam SA. Incidence and Outcomes of Bacteremia with Common Over-the-Counter Probiotic Organisms Among Hematopoietic Cell Transplant Recipients. ASBMT / CIBMTR Tandem Meeting. Grapevine, TX, February 2014. (Abstract 311 Poster)
38. Wierenga JR, Butler-Wu S, Wald A, Turner S, Stednick Z, Pergam SA. Cancer and Hematopoietic Cell Transplant Patients Drive Fluoroquinolone-resistance in Viridans Group Streptococci in a Large Tertiary Medical System. 24th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain. May 2014. (Abstract 1794 Poster)
39. Tse S, Chen TL, Pergam SA, Jain R. The evaluation of the treatment of line-associated coagulasenegative Staphylococci bacteremia in oncology patients. Western States Conference, San Diego, CA. May 2014. (Abstract 561 Oral).
40. Miles-Jay A, Stednick Z, Podczervinski S, Aker S, Helbert L, Pergam SA. Methicillin-Resistant Staphylococcus aureus Screening in Hematopoietic Cell Transplant Recipients at the Seattle Cancer Care Alliance: A Quality Assessment. APIC. Anaheim, CA, June 2014. (Abstract 3-141 Poster)
41. Podczervinski S, Fauver J, Helbert L, Minser M, Bosze J, Nolting H, Gonzalez T, Pergam SA. A Multidisciplinary Approach to Minimize Exposures to Bed Bugs (Cimex lectuaris) in a Large Ambulatory Cancer Center. APIC. Anaheim, CA, June 2014. (Abstract 7-209 Poster)
42. Sivagnanam S, Podczervinski S, Butler-Wu SW, Helbert L, Pergam SA. Role of Non-pneumolphila Species in Culture Proven Legionellosis at a Large Tertiary Medical Center. ICAAC. Washington DC, September 2014. (Abstract 3220 Poster)
43. Miles-Jay A, Rowhani-Rahbar A, Butler-Wu S, Pergam SA. Fluoroquinolone Resistant Gramnegative Bacteremia in Allogeneic Hematopoietic Cell Transplant Patients during an Era of Levofloxacin Prophylaxis. ICAAC. Washington, DC, September 2014. (Abstract 950 Oral)
44. Sahoo F, Xie H, Leisenring W, Goyal S, Yi J, Kimball L, Hill J, Schramm J, Seo S, Pergam S, Liaw KL, Holmberg L, Boeckh M. Five Year Cumulative Incidence of Herpes Zoster (HZ) in Autologous Hematopoietic Cell Transplant (HCT) Recipients who Received Long-Term Acyclovir or Valacyclovir Prophylaxis. ID Week. Philadelphia, PA, October 2014. (Abstract 436 Poster)
45. Boyle N, Podczervinski S, Morrison A, Butler-Wu S, Zerr D, Rogers K, Stednick Z, Magaret A, Wald A, Pergam SA. Evaluating Risk Factors for Clostridium difficile Infection in Adult and Pediatric Hematopoietic Cell Transplant Recipients. ID Week. Philadelphia, PA, October 2014. (Abstract 528 Oral)
46. Boeckh M, Xie Hu, Guthrie K, Pergam S, Mielcarek M, Fredricks D. Antibiotic Use Patterns Early After Hematopoietic Cell Transplantation (HCT) Influence the Risk of Viral Infections and Acute GraftVersus-Host Disease (GVHD). ID Week. Philadelphia, PA, October 2014. (Abstract 601 Oral)
Pergam, SA - CV Page 24
47. Seo S, Fan W, Hansen JA, Storer BE, Pergam SA, Green ML, Ozkok S, Goyal S, Fisher C, Hingorani S, Warren EH, Martin PJ, Zhao LP, and Boeckh M. Evaluation of Published SingleNucleotide Polymorphisms (SNPs) Associated with Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation in a Large Caucasian Cohort. American Society of Hematology (ASH) 56th Annual Meeting. San Francisco, CA, Dec 6-9, 2014. (Abstract 182 - Oral)
48. Bhattacharyya A, Fredricks DN, Srinivasan S, Morgan MT, Boeckh M, Pergam SA, Budiarto TM, Riddell SR, and Turtle CJ. Factors Influencing Reconstitution of Mucosal-Associated Invariant T Cells Following Allogeneic Hematopoietic Stem Cell Transplantation. American Society of Hematology (ASH) 56th Annual Meeting. San Francisco, CA, Dec 6-9, 2014. (Abstract 3918 - Poster)
49. Chow V, Miles-Jay A, Mielcarek M, Pergam SA. Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Allograft Recipients on High-Dose Glucocorticoids for Treatment of Graft-versus-HostDisease. ASBMT / CIBMTR Tandem Meeting. San Diego, CA February 11, 2015. (Abstract 337 Poster)
50. Price S, Podczervinski S, MacLeod K, Helbert L, Pergam SA. Understanding Influenza Vaccination Rates and Reasons for Refusal in Caregivers and Household Contacts of Cancer Patients. Association of Professionals in Infection Control (APIC) Annual Meeting, Nashville, TN, Jun 27, 2015 (Abstract 020 - Oral)
51. Sivagnanam S, Sengupta D, Hoogestraat D, Jain R, Hendrie P, Whimbey E, Podczervinski S, Pergam SA. A Cluster of Sinopulmonary Mucormycosis in Patients with Hematologic Malignancies at a Comprehensive Cancer Center. ID Week. San Diego, CA, October 2015. (Abstract 1210 - Poster)
52. Golob JL, Srinivasan S, Pergam SA, Liu C, Ko D, Aker S, Fredricks DN. Gut Microbiome Changes in Response to Protocolized Antibiotic Administration During Hematopoietic Cell Transplantation. ID Week. San Diego, CA, October 2015. (Abstract 698 - Oral)
53. Waghmare A, Kuypers J, Campbell AP, Jerome K, Englund J, Boeckh M, Pergam SA. Lack of molecular evidence of nosocomial transmission of human rhinovirus in hematopoietic cell transplant recipients. ID Week. San Diego, CA, October 2015. (Abstract 357 - Poster)
54. Howell C, MacLeod K, Huynh P, Kight-Iwayama J, Pergam SA. Donning and Doffing of PPE as a Quality Metric: An Inter-professional Educational Initiative in Oncology Ambulatory Care. Seattle Nursing Research Conference. Seattle, WA, January 2016. (Poster)
55. Sivagnanam S, Kurosawa K, Yeung C, SenGupta D, Hoogestraat D, Butler-Wu SM, Pergam SA. Assessment of Legionella PCR using Bronchoalveolar Samples in Hematopoietic Cell Transplantation. ASM Microbe 2016, Boston, MA, June 2016. (Abstract 3899 - Poster)
56. Stednick Z, Johnston C, Boeckh M, Gooley T, Pergam SA. Correlation between HSV-1 recipient serostatus and increased mortality in a large single center cohort of allogeneic hematopoietic cell transplant (HCT) recipients. ID Week. New Orleans, LA, October 2016. (Abstract 2326 Poster, *selected for Transplant ID poster rounds)
57. Jain R, Chin A, Fredricks DN, Pergam SA. Serum Concentrations of Posaconazole (PCZ) with Delayed-Release Tablets (DRT) in High-risk Patients. ID Week. New Orleans, LA, October 2016. (Abstract 1628 - Poster)
58. Boonyaratanakornkit J, Limaye A, Pergam SA. Survivor: Fevers in a Heart Transplant Patient. ID Week. New Orleans, LA, October 2016. (Abstract - Poster)
59. MacAllister T, Stednick Z, Huang M, Pergam SA. Is Norovirus Laboratory Testing within a Large Cancer Center Underutilized? Possible Implications for Infection Prevention. APIC. Portland, OR, June 2017. (Abstract - Poster)
60. Knight J, Campbell A, Chadduck K, MacLeod K, Pergam SA. Utilizing a Novel Online Learning System to Reinforce and Standardize Transmission Precaution Practices in Ambulatory Cancer Clinic. APIC. Portland, OR, June 2017. (Abstract - Poster)
61. Boeckh M, Arvin A, Mullane K, Winston D, Brown J, Pergam SA, Hurtado K, Pang L, Lee I, Popmihajlov Z. Immunogenicity of inactived varicella zoster vaccine (ZVin) in autologous
Pergam, SA - CV Page 25
hematopoietic stem cell transplant (auto-HSCT) recipients. Infectious Disease Society of America (IDSA). San Diego, CA, 10/2017. (Abstract 64173 Oral presentation)
62. Vivek M, Xie H, Pergam SA, Mielcarek M, Hill J, Kuypers J, Jerome K, Limaye A, Leisenring W, Boeckh M, Waghmare A. Does Detection of Respiratory Viral Infection in Upper Respiratory Tract (URT) Predict Lower Respiratory Tract (LRT) Disease in Hematopoietic Cell Transplant (HCT) Patients? Infectious Disease Society of America (IDSA). San Diego, CA, 10/2017 (Abstract Oral presentation)
63. Kim YJ, Waghmare, Kuypers J, Jerome K, Pergam SA, Xie H, Leisenring WM, Ogimi C, Boeckh M, Englund JA Impact of Pretransplant Respiratory Virus Detection through Universal Screening in Children Undergoing Hematopoietic Cell Transplantation (HCT) Infectious Disease Society of America (IDSA). San Diego, CA, 10/2017. (Abstract Oral presentation)
64. MacAllister T, Stohs E, Liu C, Amanda Phipps A, Pergam SA. Ten Year Trends in Incidence of Vancomycin-resistant Enterococcus Among Allogeneic Hematopoietic Cell Transplant Recipients. Infectious Disease Society of America (IDSA). San Diego, CA, 10/2017 (Abstract Poster)
65. Stohs E, MacAllister T, Pergam SA, Jain R, Liu C. Unintended Consequences of Pre-transplant VRE Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients. Infectious Disease Society of America (IDSA). San Diego, CA, 10/2017 (Abstract Poster)
66. Woodfield MC, Cheng GS, Baker KK, Fann JR, Lee CM, Holmberg LA, Courtnage TJ, Pergam SA. Assessing cannabis use among hematopoietic cell transplant recipients from a center in a state with legalized recreational use. American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Salt Lake City, UT. Feb 2018. (Abstract 289 - Poster)
67. Hill JA, Pergam SA, Cox E, Xie H, Leisenring WM, Boeckh M, Delaney C, Milano F. A modified intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Salt Lake City, UT. Feb 2018. (Abstract 93 Oral presentation)
68. Ford ES, Duke ER, Schiffer JT, Pergam SA, Cheng GS, Liu C, Hill JA, Golob JL, Mattson DK, Yoke LM, Bhattacharyya P, Geballe AP, Corey L, Wald A, Fredricks D, Boeckh M. Outcome of hematopoietic cell transplantation (HCT) in patients with invasive fungal infection (IFI) before HCT without regression or stabilization of radiographic signs. American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Salt Lake City, UT. Feb 2018. (Abstract Poster)
69. Ogimi C, Golob JL, Krantz E, Waghmare A, Liu C, Leisenring WM, Xie H, Stednick Z, Woodard C, Marquis S, Nguyen E, Chung L, Goyal S, Kimball L, Kuypers JM, Jerome KR, Pergam SA, Fredricks DN, Englund JA, Boeckh M. Antibiotic Exposure Prior to Respiratory Viral Infection is Associated with Disease Progression to Lower Respiratory Tract Infection in Allogeneic Hematopoietic Cell Transplantation Recipients. American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Salt Lake City, UT. Feb 2018. (Abstract Poster)
70. Fann JR, Pergam SA, Woodfield M, Cheng GS, Baker K, Abdallah D, Lee C. Cancer healthcare provider perceptions and practice patterns regarding patients' cannabis use in a state with legalized medicinal and recreational use. Annual Meeting of the American Psychosocial Oncology Society, Tucson, AZ Feb 2018. (Abstract Poster)
71. Roncaioli S, Bryan A, Stohs E, Liu C, Sweet A, Pergam SA. Breakthrough Pneumocystis jirovecii Pneumonia among Cancer Patients: Opportunity for Antimicrobial Stewardship? ID Week, San Diego, CA 2018. (Abstract Poster)
72. Stohs E, Sweet A, Zier J, Krantz E, Pergam SA, Liu C. Antibiotic Prescribing Knowledge: A Brief Survey of Providers and Staff at an Ambulatory Cancer Center during Antibiotic Awareness Week 2017. ID Week, San Diego, CA October 2018. (Abstract Poster)
73. Golob JL, Stohs E, Sweet A, Pergam SA, Fredricks DN, Liu C. Vancomycin is Frequently Administered to Hematopoietic Cell Transplant Recipients Without a Provider Documented Indication and Correlates with Microbiome Disruption and Adverse Events. ID Week, San Diego, CA October 2018. (Abstract Poster)
Pergam, SA - CV Page 26
74. Imlay H, Xie H, Leisenring WM, Kimball L, Pergam SA, Limaye AP, Boeckh M. Clinical Presentation of BK virus-associated hemorrhagic cystitis (HC) after hematopoietic cell transplantation (HCT). ID Week, San Diego, CA October 2018. (Abstract Poster)
75. Freifeld AG, Zimmer A, Arnold C, Baddley JW, Chandrasekar P, El Boghdadly Z, Maziarz EK, Montoya JG, Pergam SA, Rolston KV, Satyanarayana G, Shoham S, Strasfeld L, Taplitz R, Walsh TJ, Young JA, Zhang Y, Meza J. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) with Fever and Neutropenia : Predictors for Morbidity and Mortality. ID Week, San Diego, CA October 2018. (Abstract Poster)
76. Zimmer A, Freifeld AG, Arnold C, Baddley JW, Chandrasekar P, El Boghdadly Z, Maziarz EK, Montoya JG, Pergam SA, Rolston KV, Satyanarayana G, Shoham S, Strasfeld L, Taplitz R, Walsh TJ, Young JA, Zhang Y, Meza J. Bloodstream Infection Survey in High-risk Oncology Patients (BISHOP) with Fever and Neutropenia: Correlation between Initial Empiric Antibiotic Regimen Correlation and Susceptibility Patterns. ID Week, San Diego, CA October 2018. (Abstract Poster)
77. Sosa Moreno A, Swetky M, Podczervinski S, Narita M, Spitters C, Edelstein R, Pergam SA. Targeted Screening Program for latent TB infection among hematopoietic cell transplant recipients. American Public Health Association Meeting & Expo San Diego, CA November 2018 (Abstract Poster)
78. Thomas L, Batarseh E, Hamdan L, Dulek D, Piya B, Stewart L, McHenry R, Ison M, Overton ET, Pergam S, Halasa N. Respiratory Virus Infection in Adult Hematopietic Cell Transplant Recipients during the 2017/2018 Influenza Season. ISIRV 6th Annual Conference. Washington, DC. November 2018 (Abstract- Poster)
79. Sheih A, Golob J, Bhattacharyya A, We M, Vakil A, Srinivasan S, Pergam SA, Fredricks D, Turtle C. Impact of intestinal microbiota on reconstitution of mucosal-associated invariant T cells after allogeneic hematopoietic stem cell transplantation. American Society of Hematology 60th Annual Meeting and Exposition December 2018 San Diego (Abstract Poster)
80. Boonyaratanakornkit J, Xie H, Waghmare A, Campbell A, Cheng GS, Davis C, Kuypers J, Chien J, Pergam SA, Liu C, Callais C, Jerome K, Leisenring W, Englund J, Boeckh M. Early Respiratory Viral Acquisition after Allogeneic Hematopoietic Cell Transplant (HCT) Transplantation and Cellular Therapy Meetings (TCT). Houston, TX. Feb 2019. (Abstract 517 Poster)
81. Ogimi C, Englund J, Leisenring W, Cheng GS, Waghmare A, Jerome K, Kuypers J, Chien J, Callais C, Pergam SA, Xie H. Human Metapneumovirus or Influenza A Upper Respiratory Tract Infection Associated with Increased Risk of Bacterial Superinfection in Allogeneic Hematopoietic Cell Transplant Recipients. Transplantation and Cellular Therapy Meetings (TCT) Houston, TX. Feb 2019. (Abstract 1587 Poster)
82. McMillen KK, Schmidt EM, Rasmussen M, Buono L, Macris P, Price S, Baker K, Pergam SA. Efficacy of Evidence-Based Group Safety Education for Hematopoietic Cell Transplant (HCT) Patients. Transplantation and Cellular Therapy Meetings (TCT) Houston, TX. Feb 2019. (Abstract 671 Poster)
83. Swetky M, Chadduck K, Loder D, Stricker K, Maletich K, Pergam SA. Healthcare Workers Knowledge and Perceptions of Coming to Work Sick at a Large Comprehensive Cancer Center. APIC 46th Annual Conference in Philadelphia, PA, June 12-14, 2019 (Abstract 138 Poster)
84. Lind M, Phipps A, Liu C, Klassen J, Davis C, Pergam SA. Evaluation of Sepsis Definitions in
Immunocompromised Patients. Society for Epidemiologic Research (SER) Annual Meeting 6/18-6/21 2019
85. Thomas L, Batarseh E, Hamdan L, Stewart L, Rahman H, Dulek D, Spieker A, Ison M, Overton E, Pergam SA, Halasa N. Safety of Influenza Vaccine in Adult Hematopoietic Stem Cell Transplant Recipients. Options X for the Control of Influenza Conference, 8/28-9/1 2019 Suntec, Singapore
86. Golob, J, DeMeules M, Quinn M, Loeffelholz M, Silvestri S, Wu, MC, Schmidt T, Fiedler T, Hoostal M, Mielcarek M, Spence J, Pergam SA, Fredricks D. Butyrogenic Bacteria after Acute Graft Versus Host Disease Associate with the Development of Steroid Refractory GVHD ID Week, Washington DC October 2019. (Abstract Talk)
Pergam, SA - CV Page 27
87. Liu C, Krantz E, Stohs ES, Imlay H, Rampur L, Zier J, Sweet A, Pergam SA, Mielcarek M, Henderson W, Altman M Feasibility and Outcomes of a Pre-Transplant Antibiotic Allergy Evaluation Program for Allogeneic Hematopoietic Cell Transplant (HCT) Candidates ID Week, Washington DC October 2019. (Abstract Poster)
88. Imlay H, Krantz E, Stohs ES, Lan KF, Kim NH, Rakita R, Limaye AP, Wald A, Pergam SA, Liu C Beta lactam and other antibiotic allergies in patients undergoing solid organ and hematopoietic stem cell transplantation ID Week, Washington DC October 2019. (Abstract Poster)
89. McKay SL, Guo A, Pergam SA, Dooling K. Herpes Zoster Risk in Immunocompromised Adults in the US: A Systematic Review. ID Week, Washington DC October 2019. (Abstract Poster)
90. Stohs EJ, Zimmer A, Fey P, Handke L, Zhang Y, Taplitz R, Strasfeld L, Arnold C, El Boghdadly A, Baddley J, Pergam SA, Freifeld A. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) with Fever and Neutropenia (FN): Viridans Group Streptococcus Emerges as an Important Pathogen, ID Week, Washington DC, October 2019
91. Xue E, Leisenring W, Kimball L, Goyal S, Chung EL, Blazevic RL, Maltez B, Salit RB, Dahlberg AE, Delaney C, Pergam SA, Boeckh M High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis 61st ASH Annual Meeting & Exposition December 7-10, 2019 Orlando, FL (Abstract Poster)
92. Maravilla Rosas, MJ, McFarland L, Taylor L, Olson S, Pergam SA, Lind M. Assessing the Relationship between Glasgow Coma Scale Scores and MS Documentation in Allogeneic Hematopoietic Cell Transplant Recipients with Suspected Infection American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Orlando, FL. Feb 2020. (Abstract Poster)
93. Lind M, Roncaioli S, Phipps A, Liu C, Bryant A, Sweet A, Pergam SA. Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Orlando, FL. Feb 2020. (Abstract Poster)
94. Taylor L, Olson S, Swetky M, Walji S, Pergam SA Sweet A, Liu C. An Interdisciplinary Team
Decreases Hospital Acquired Infections in HCT Patients American Society of Blood and Marrow Transplant/ CIBMTR Tandem Meeting. Orlando, FL. Feb 2020. (Abstract Poster)
17. NATIONAL AND INTERNATIONAL LECTURES
1. "The Top Ten Papers in Transplant Infectious Diseases." 48th Annual Infectious Diseases Society of America. Vancouver, BC. Oct 2010.
2. "Looking through the Prism of Transplantation: The Spectrum of Infectious Disease Complications." Interlink Health Services Medical Round Table. Apr 2011. (Webinar)
3. "Infectious Disease in Transplantation." Interlink Health Services, Seattle, WA. Jul 2011
4. "The Top Ten Papers in Transplant Infectious Diseases." 49th Annual Infectious Diseases Society of America. Boston, MA. Oct 2011
5. "Herpes Zoster in Moderately Immunosuppressed Patients: Disease Burden and Implications for Vaccination." 49th Annual Infectious Diseases Society of America, Boston, MA. Oct 2011.
6. "Understanding risk, prevention and diagnostics of CMV disease in hematopoietic cell transplant recipients." Northwest Society of Microbiology Branch Meeting. Seattle, WA. Nov 2011.
7. "Developing a Microbiome Protocol", Mixed Chimerism Investigators' Meeting. Seattle, WA. March 2012.
8. "Infection Control Best Practices", Global Patient Safety Practice Policy and Assurance System Conference, Shengjing Hospital of China Medical University, Shenyang, China, Aug, 2014.
9. "Top Ten Papers in Transplant Infectious Disease" ID Week, Philadelphia, PA, Oct 10, 2014.
10. "Infection Control Lessons from the Immunocompromised Host", Wenatchee Valley Medical Center, Moses Lake, WA, Oct 24, 2014.
Pergam, SA - CV Page 28
11. "Respiratory Viruses Update: Epidemiology, Treatment and Prevention of the `Uncommon' Cold" Northwest Hospital Grand Rounds (CME), Seattle, WA, Oct 28, 2014.
12. "Legionella", Puget Sound APIC, Tukwila, WA, Nov 20, 2014
13. "Clinical Challenges in Transplant Patients with Viral Infections", BMT Faculty Presentation, St. Louis University, St. Louis, MO, Dec 17, 2014
14. "When Its More Than the Common Cold: Respiratory Viruses in the Immunocompromised Host", Hem/Onc Grand Rounds (CME), St. Louis University, St. Louis, MO, Dec 18, 2014
15. "Strep Viridans in Cancer & Transplant Patients", AML Faculty Meeting, Fred Hutchinson Cancer Research Center, Seattle, WA, April 3, 2015.
16. "Parainfluenza 3 in the Puget Sound", Office of Communicable Disease Epidemiology, Division of Disease Control & Health Statistics, Washington State Department of Health, Shoreline, WA, Jun 23, 2015.
17. "Infection Prevention Strategies in the Immunocompromised Host", Association of Professionals in Infection Control (APIC) Annual Meeting, Nashville, TN, Jun 28, 2015
18. "Infection Prevention and Facilities/Construction Management", Washington State Society for Healthcare Engineering, Seattle, WA, July 8, 2015.
19. "Emerging Infections in Adult Transplant Patients", International Conference on Emerging Infectious Diseases (ICEID), Atlanta, GA, Aug 24-26, 2015
20. "Challenging Cases in Transplant Infectious Diseases", Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/International Congress on Chemotherapy (ICC) San Diego, CA, Sep 2015.
21. "Primer on Infections in Hematopoietic Stem Cell Transplant Patients" Pre-Meeting Workshop Moderator, Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/International Congress on Chemotherapy (ICC) San Diego, CA, Sep 2015.
22. "Preventing Respiratory Viruses in Cancer and Transplant Patients - Preparing for the 2015-2016 Season", Northwest Hospital & Medical Center Grand Rounds (CME), Seattle, WA, Sept 22, 2015
23. "Infection Prevention in Facilities Maintenance", Northwest Hospital & Medical Center, Seattle, WA, Sept 22, 2015
24. "Mold and the Environment", Infection in Immunocompromised Patients Conference, University of São Paulo, Brazil, November 17, 2015.
25. "Multidrug resistance in the Transplant Setting", Infection in Immunocompromised Patients Conference, University of São Paulo, Brazil, November 18, 2015.
26. "Sequencing analysis of a large parainfluenza virus outbreak", 2016 Research Symposium for Fred Hutch Infectious Disease Sciences Program and University of Washington Virology Division, Seattle, WA, January 7, 2016
27. "To Screen or Not to Screen that is the Question: Screening at a High-risk Cancer Center." Washington State Department of Health, Webinar Series on Managing High-risk Pathogens in Healthcare, March 3, 2016.
28. "Viral Infections in the Pediatric Hematology/Oncology Patient", ASM Microbe 2016, Boston, MA, June 20, 2016.
29. "Infection Prevention during Construction of Healthcare Facilities", Puget Sound APIC Fall Conference, University Place, WA, Oct 14, 2016.
30. "Molecular epidemiology of a parainfluenza outbreak in cancer patients", 2017 Research Symposium for Fred Hutch Infectious Disease Sciences Program and University of Washington Virology Division, Seattle, WA, January 17, 2017
31. "Infection prevention issues in the US", National Centre for Infections in Cancer (NCIC)'s Hematology Oncology Program Lecture Seris, Melbourne, Australia August 11, 2017
Pergam, SA - CV Page 29
32. "Antibiotic Stewardship in US Cancer Hospitals: Opportunities/Challenges", National Centre for Infections in Cancer (NCIC)'s Hematology Oncology Program Inaugural Conference, Melbourne, Australia August 11, 2017
33. "Emerging Issues of Cancer, HCT and Cannabis" Vanderbilt University, Nashville, TN August 16, 2017
34. "Infection Control in the Hospital and Community" What's New in Medicine (WNIM), Kennewick, WA September 8, 2017
35. "Legionella Infections in Immunocompromised Patients: Clinical and Outbreak-Related Considerations" ID Week, San Diego, CA October 6, 2017
36. "Challenging Transplant Cases: When Transplant ID Specialists say, What?!" Panel Discussion, ID Week, San Diego, CA, October 7, 2017
37. "Psychosocial Concerns in Cancer Survivorship", Panel Discussion, 4th Symposium on Cancer Survivorship for Clinicians, Seattle, WA, October 27th, 2017
38. "Viral Infections in Transplant Patients" 4th Annual American Society of Blood and Marrow Transplant Fall Clinical Education Conference, Seattle, WA, October 28th, 2017
39. "Emerging Issues of Marijuana in Cancer Care" 4th Symposium on Cancer Survivorship for Clinicians, Seattle, WA, October 28th, 2017
40. "Basics of Hematopoietic Cell Transplant: Focus on Autotransplantation" ACIP Zoster Working Group, January 8, 2018
41. "Infectious Diseases in HCT: What are the New Bugs and Drugs?" ASBMT Tandem Meetings, Salt Lake City, UT February 28, 2018
42. "Methods to Enhance Vaccination among Clinical and Non-clinical staff at a Large Comprehensive Cancer Center" Washington State Hospital Association. Seattle, WA July 25, 2018
43. "Emerging issues of Marijuana in Cancer Care" University of Washington Dermatology Grand Rounds, Seattle, WA, September 24, 2018
44. "Water Management Programs, Legionella and Waterborne Pathogens in Healthcare" Intermountain APIC Conference. Boise, ID, October 24, 2018
45. "Emerging issues of Marijuana in Cancer Care" Team Survivor Northwest Fitness Retreat, Bainbridge Island, WA February 2, 2019
46. "Cannabis, Cancer and Immunosuppressed Hosts" Medical Grand Rounds Lecture Series at Northwestern University's Feinberg School of Medicine as the Transplant ID Visiting Professorship February 5, 2019
47. "Weeding Out the Truth About Cannabis" Transplantation and Cellular Therapies Meetings. Houston, TX February 21, 2019.
48. Cannabis, Cancer and Immunosuppressed Hosts, MD2 WebEx Grand Rounds, Seattle, WA April 23, 2019
49. "Vaccination in the Modern Era" Grays Harbor College, Aberdeen, WA, May 8, 2019 50. "Measles and the Rise of the Anti-vaccine Movement." Comprehensive Cancer Center Consortium
Quality Improvement (C4QI) Seattle, WA, May 9, 2019 51. "Challenges and Controversies of Infection prevention in High-Risk Cancer Patients" @C3CIC
Seattle, WA May 9, 2019 52. "Measles, Not Just Your Grandmother's Disease" Southern California Branch of the American Society
for Microbiology (SCASM) Annual Meeting San Diego, CA, October 26, 2019 53. "Measles: Educator Session" Southern California Branch of the American Society for Microbiology
(SCASM) Annual Meeting San Diego, CA, October 26, 2019 54. "Resurgence of Once Uncommon Infections; Implications for Immunocompromised Hosts" City of
Hope, Duarte, CA November 26, 2019 55. "Vaccination with MMR in an Era of Measles Reemergence" Transplantation and Cellular Therapies
Meetings, Orlando, FL, February 19-23, 2020
Pergam, SA - CV Page 30
56. "Understanding Medical Marijuana: It's a Joint Effort" 3rd annual Komen Chicago metastatic breast cancer conference Chicago, IL April 3-4th 2020
57. "Understanding Medical Marijuana: It's a Joint Effort" CancerCon, Seattle, WA April 16-19, 2020
Pergam, SA - CV Page 31
Microsoft Word for Office 365